Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 152
Encontrada(s) 2 página(s)

e-Archivo. Repositorio Institucional de la Universidad Carlos III de Madrid
Publication Artículo científico (JournalArticle)

Fibroblast activation and abnormal extracellular matrix remodelling as common hallmarks in three cancer-prone genodermatoses

  • Chacón Solano, Esteban
  • León Canseco, Carlos
  • Diaz, F.
  • García-García, F.
  • García Díez, Marta
  • Escámez Toledano, María José
  • Guerrero Aspizua, Sara
  • Conti, Claudio Jorge
  • Mencía Rodríguez, Ángeles
  • Martínez Santamaría, Lucía
  • Llames, S.
  • Pévida, M.
  • Carbonell-Caballero, J.
  • Puig-Butille, J.A.
  • Maseda, R.
  • Puig, S.
  • Lucas, R. de
  • Baselga, E.
  • Larcher Laguzzi, Fernando
  • Dopazo, J.
  • Río Nechaevsky, Marcela del
Incluye dataset como material suplementario, Background. Recessive dystrophic epidermolysis bullosa (RDEB), Kindler syndrome (KS) and xeroderma pigmentosum complementation group C (XPC) are three cancer-prone genodermatoses whose causal genetic mutations cannot fully explain, on their own, the array of associated phenotypic manifestations. Recent evidence highlights the role of the stromal microenvironment in the pathology of these disorders. Objectives. To investigate, by means of comparative gene expression analysis, the role played by dermal fibroblasts in the pathogenesis of RDEB, KS and XPC. Methods. We conducted RNA-Seq analysis, which included a thorough examination of the differentially expressed genes, a functional enrichment analysis and a description of affected signalling circuits. Transcriptomic data were validated at the protein level in cell cultures, serum samples and skin biopsies. Results. Interdisease comparisons against control fibroblasts revealed a unifying signature of 186 differentially expressed genes and four signalling pathways in the three genodermatoses. Remarkably, some of the uncovered expression changes suggest a synthetic fibroblast phenotype characterized by the aberrant expression of extracellular matrix (ECM) proteins. Western blot and immunofluorescence in situ analyses validated the RNA-Seq data. In addition, enzyme-linked immunosorbent assay revealed increased circulating levels of periostin in patients with RDEB. Conclusions. Our results suggest that the different causal genetic defects converge into common changes in gene expression, possibly due to injury-sensitive events. These, in turn, trigger a cascade of reactions involving abnormal ECM deposition and underexpression of antioxidant enzymes. The elucidated expression signature provides new potential biomarkers and common therapeutic targets in RDEB, XPC and KS., This study was supported by grants from the Spanish Ministry of Economy and Competitiveness (SAF2013-43475R, SAF2017-88908-R and SAF2017-86810-R); from Instituto de Salud Carlos III and CIBERER, cofunded with European Regional Development Funds (ERDF) (PT13/0001/0007, PI14/00931, PI15/00716, PI15/00956, PT17/0009/0006 and PI17/01747); and from the European Union (HEALTH-F2-2011-261392 and H2020-INFRADEV-1-2015-1/ELIXIR-EXCELERATEref. 676559). Additional funding from Comunidad de Madrid (AvanCell-CM S2017/BMD-3692); Catalan Government (AGAUR 2014_SGR_603); ‘Fundacio' La Marató de TV3, 01331-30’; CERCA Programme/Generalitat de Catalunya; and ‘Fundación Científica de la Asociación Española Contra el Cáncer’, Spain.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

From Wet-Lab to Variations: Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome Sequencing

  • Laurie, Steven, 1973-
  • Fernández Callejo, Marcos
  • Marco Sola, Santiago
  • Trotta, Jean-Remi
  • Camps-Puchadas, Jordi
  • Chacón, Alejandro
  • Espinosa, Antonio
  • Gut, Marta
  • Gut, Ivo Glynne
  • Heath, Simon
  • Beltran, Sergi
As whole genome sequencing becomes cheaper and faster, it will progressively substitute targeted next-generation sequencing as standard practice in research and diagnostics. However, computing cost–performance ratio is not advancing at an equivalent rate. Therefore, it is essential to evaluate the robustness of the variant detection process taking into account the computing resources required. We have benchmarked six combinations of state-of-the-art read aligners (BWA-MEM and GEM3) and variant callers (FreeBayes, GATK HaplotypeCaller, SAMtools) on whole genome and whole exome sequencing data from the NA12878 human sample. Results have been compared between them and against the NIST Genome in a Bottle (GIAB) variants reference dataset. We report differences in speed of up to 20 times in some steps of the process and have observed that SNV, and to a lesser extent InDel, detection is highly consistent in 70% of the genome. SNV, and especially InDel, detection is less reliable in 20% of the genome, and almost unfeasible in the remaining 10%. These findings will aid in choosing the appropriate tools bearing in mind objectives, workload, and computing infrastructure available., Contract Grant Sponsors: Spanish Ministry of Economy and Competitiveness; Generalitat de Catalunya; European Regional Development Fund (ERDF); RD-Connect Project (EC FP7/2007-2013 #305444); ELIXIR-EXCELERATE (EC H2020 #676559); MICINN (TIN2014-53234- C2-1-R).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The effects of death and post-mortem cold ischemia on human tissue transcriptomes

  • Ferreira, Pedro G.
  • Muñoz-Aguirre, Manuel
  • Reverter Comes, Ferran
  • Godinho, Caio P. Sá
  • Sousa, Abel
  • Amadoz, Alicia
  • Sodaei, Reza, 1988-
  • Hidalgo, Marta R.
  • Pervouchine, Dmitri D.
  • Carbonell-Caballero, Jose
  • Nurtdinov, Ramil
  • Breschi, Alessandra, 1988-
  • Amador, Raziel
  • Oliveira, Patrícia
  • Çubut, Cankut
  • Curado, Joao
  • Aguet, François
  • Oliveira, Carla
  • Dopazo, Joaquín
  • Sammeth, Michael
  • Ardlie, Kristin G.
  • Guigó Serra, Roderic
Post-mortem tissues samples are a key resource for investigating patterns of gene expression. However, the processes triggered by death and the post-mortem interval (PMI) can significantly alter physiologically normal RNA levels. We investigate the impact of PMI on gene expression using data from multiple tissues of post-mortem donors obtained from the GTEx project. We find that many genes change expression over relatively short PMIs in a tissue-specific manner, but this potentially confounding effect in a biological analysis can be minimized by taking into account appropriate covariates. By comparing ante- and post-mortem blood samples, we identify the cascade of transcriptional events triggered by death of the organism. These events do not appear to simply reflect stochastic variation resulting from mRNA degradation, but active and ongoing regulation of transcription. Finally, we develop a model to predict the time since death from the analysis of the transcriptome of a few readily accessible tissues., This work was supported by the following grants and contracts: 1) From the US NIH: Contract HHSN261200800001E (Leidos Prime contract with NCI); Contracts 10XS170 (NDRI), 10XS171 (Roswell Park Cancer Institute), 10 × 172 (Science Care Inc.), and 12ST1039 (IDOX); Contract 10ST1035 (Van Andel Institute); Contract HHSN268201000029C (Broad Institute); R01 DA006227-17 (U Miami Brain Bank) 2) Ipatimup and i3s are partially funded by the Portuguese Foundation for Science and Technology (FCT); FEDER funds through the COMPETE 2020—Operacional Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT/MCTES in the framework POCI-01-0145-FEDER-007274; 3) NORTE-01-0145-FEDER-000029, supported by NORTE 2020, under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); 4) FCT Fellowships SFRH/BPD/89764/2012 to PO, PD/BD/128007/2016 to AS; Salary support to PGF by POPH—QREN Type 4.2, European Social Fund and MCTES, program Investigador FCT, IF/01127/2014. 5) BIO2014-57291-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 from the ISCIII, and EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE (ref. 6,676559) Spanish Ministry of Economy and Competitiveness, ‘Centro de Excelencia Severo Ochoa 2013-2017’ and CERCA Programme/Generalitat de Catalunya, 7) Ministerio de Educación, Cultura y Deporte, under the FPU programme (Formación de Profesorado Universitario) with pre-doctoral fellowship FPU15/03635 to MMA. 8) Award Number 1R01MH101814 and 3R01MH101814-03S1 from the National Human Genome Research Institute. European Research Council under the European Union’s Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement RNA-MAPS_294653, Ministerio de Economía, Industria y Competitividad, referencia MEIC BIO2015-70777-P y los Fondos Estructurales de la Unión Europea (FEDER) and ISCIII del Ministerio de Economía y Competitividad, referencia PT13/0001/0021 cofinaciada por el Fondo Europeo de Desarrollo Regional (FEDER). 9) MS received funding from CNPq (grant 310132/2015-0 and 427541/2016-6), and from FAPERJ (grant E_06/2015).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

CSVS, a crowdsourcing database of the Spanish population genetic variability

  • Peña-Chilet, María
  • The Spanish Exome Crowdsourcing Consortium
  • Dopazo, Joaquín
The knowledge of the genetic variability of the local population is of utmost importance in personalized medicine and has been revealed as a critical factor for the discovery of new disease variants. Here, we present the Collaborative Spanish Variability Server (CSVS), which currently contains more than 2000 genomes and exomes of unrelated Spanish individuals. This database has been generated in a collaborative crowdsourcing effort collecting sequencing data produced by local genomic projects and for other purposes. Sequences have been grouped by ICD10 upper categories. A web interface allows querying the database removing one or more ICD10 categories. In this way, aggregated counts of allele frequencies of the pseudo-control Spanish population can be obtained for diseases belonging to the category removed. Interestingly, in addition to pseudo-control studies, some population studies can be made, as, for example, prevalence of pharmacogenomic variants, etc. In addition, this genomic data has been used to define the first Spanish Genome Reference Panel (SGRP1.0) for imputation. This is the first local repository of variability entirely produced by a crowdsourcing effort and constitutes an example for future initiatives to characterize local variability worldwide. CSVS is also part of the GA4GH Beacon network., Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R, PT17/0009/0006 to J.D.; PI19/00321 and CIBERER ACCI-06/07/0036 to C.A., PI14-948, PI17-1659 and CIBERER ACCI-06/07/0036 to M.A.M.P.]; Regional Government of Madrid, RAREGenomics-CM [B2017/BMD-3721 to C.A. and B2017/BMD3721 to M.A.M.P.]; all co-funded with European Regional Development Funds (ERDF) as well as EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE [676559]; University Chair UAM-IIS-FJD of Genomic Medicine and the Ramon Areces Foundation also supported this work. Funding for open access charge: Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Network, transcriptomic and genomic features differentiate genes relevant for drug response

  • Piñero González, Janet, 1977-
  • Gonzalez-Perez, Abel
  • Guney, Emre
  • Aguirre Plans, Joaquim, 1993-
  • Sanz, Ferran
  • Oliva Miguel, Baldomero
  • Furlong, Laura I., 1971-
Understanding the mechanisms underlying drug therapeutic action and toxicity is crucial for the prevention and management of drug adverse reactions, and paves the way for a more efficient and rational drug design. The characterization of drug targets, drug metabolism proteins, and proteins associated to side effects according to their expression patterns, their tolerance to genomic variation and their role in cellular networks, is a necessary step in this direction. In this contribution, we hypothesize that different classes of proteins involved in the therapeutic effect of drugs and in their adverse effects have distinctive transcriptomics, genomics and network features. We explored the properties of these proteins within global and organ-specific interactomes, using multi-scale network features, evaluated their gene expression profiles in different organs and tissues, and assessed their tolerance to loss-of-function variants leveraging data from 60K subjects. We found that drug targets that mediate side effects are more central in cellular networks, more intolerant to loss-of-function variation, and show a wider breadth of tissue expression than targets not mediating side effects. In contrast, drug metabolizing enzymes and transporters are less central in the interactome, more tolerant to deleterious variants, and are more constrained in their tissue expression pattern. Our findings highlight distinctive features of proteins related to drug action, which could be applied to prioritize drugs with fewer probabilities of causing side effects., We received support from ISCIII-FEDER (PI13/00082, CP10/00524, and CPII16/00026), IMI-JU under grant agreements no. 116030 (TransQST) and no. 777365 (eTRANSAFE) resources of which are composed of financial contribution from the EU-FP7 (FP7/2007-2013) and EFPIA companies in kind contribution, and the EU H2020 Program 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and was supported by grant PT13/0001/0023, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER. The DCEXS is a “Unidad de Excelencia María de Maeztu”, funded by the MINECO (ref: MDM-2014-0370). AG-P was supported by a Ramón y Cajal contract (RYC-2013-14554). BO and JA-P were supported by MINECO grant BIO2014-57518-R.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

GUILDify v2.0: a tool to identify molecular networks underlying human diseases, their comorbidities and their druggable targets

  • Aguirre Plans, Joaquim, 1993-
  • Piñero González, Janet, 1977-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
  • Fernández Fuentes, Narcís
  • Oliva Miguel, Baldomero
  • Guney, Emre
The genetic basis of complex diseases involves alterations on multiple genes. Unraveling the interplay between these genetic factors is key to the discovery of new biomarkers and treatments. In 2014, we introduced GUILDify, a web server that searches for genes associated to diseases, finds novel disease genes applying various network-based prioritization algorithms and proposes candidate drugs. Here, we present GUILDify v2.0, a major update and improvement of the original method, where we have included protein interaction data for seven species and 22 human tissues and incorporated the disease-gene associations from DisGeNET. To infer potential disease relationships associated with multi-morbidities, we introduced a novel feature for estimating the genetic and functional overlap of two diseases using the top-ranking genes and the associated enrichment of biological functions and pathways (as defined by GO and Reactome). The analysis of this overlap helps to identify the mechanistic role of genes and protein-protein interactions in comorbidities. Finally, we provided an R package, guildifyR, to facilitate programmatic access to GUILDify v2.0 (http://sbi.upf.edu/guildify2)., The authors received support from the following:ISCIII–FEDER (PI13/00082, CP10/00524, CPII16/00026); IMI-JU under grants agreements no. 116030(TransQST) and no. 777365 (eTRANSAFE), re-sources of which are composed of financial contribu-tion from the EU-FP7 (FP7/2007- 2013) and EFPIAcompanies in kind contribution; the EU H2020Programme 2014–2020 under grant agreementsno. 634143 (MedBioinformatics) and no. 676559(Elixir-Excelerate); the Spanish Ministry of Economy(MINECO) (BIO2017-85329-R, RYC-2015-17519);and“Unidad de Excelencia María de Maeztu,”fundedby the Spanish Ministry of Economy (ref.: MDM-2014-0370). The Research Programme on BiomedicalInformatics is a member of the Spanish NationalBioinformatics Institute, PRB2-ISCIII, and is supportedby Grant PT13/0001/0023 of the PE I+D+i 2013-2016funded by ISCIII and FEDER
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Proximal pathway enrichment analysis for targeting comorbid diseases via network endopharmacology

  • Aguirre Plans, Joaquim, 1993-
  • Piñero González, Janet, 1977-
  • Menche, Jörg
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
  • Schmidt, Harald H.H.W.
  • Oliva Miguel, Baldomero
  • Guney, Emre
The past decades have witnessed a paradigm shift from the traditional drug discovery shaped around the idea of "one target, one disease" to polypharmacology (multiple targets, one disease). Given the lack of clear-cut boundaries across disease (endo)phenotypes and genetic heterogeneity across patients, a natural extension to the current polypharmacology paradigm is to target common biological pathways involved in diseases via endopharmacology (multiple targets, multiple diseases). In this study, we present proximal pathway enrichment analysis (PxEA) for pinpointing drugs that target common disease pathways towards network endopharmacology. PxEA uses the topology information of the network of interactions between disease genes, pathway genes, drug targets and other proteins to rank drugs by their interactome-based proximity to pathways shared across multiple diseases, providing unprecedented drug repurposing opportunities. Using PxEA, we show that many drugs indicated for autoimmune disorders are not necessarily specific to the condition of interest, but rather target the common biological pathways across these diseases. Finally, we provide high scoring drug repurposing candidates that can target common mechanisms involved in type 2 diabetes and Alzheimer's disease, two conditions that have recently gained attention due to the increased comorbidity among patients., The authors received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 116030. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. The authors also received support from EU H2020 Programme 2014–2020 under grant agreement No. 676559 (Elixir-Excelerate). E.G. was supported by EU-cofunded Beatriu de Pinós incoming fellowship from the Agency for Management of University and Research Grants (AGAUR) of Government of Catalunya and L.I.F. received support from ISCIII-FEDER (CPII16/00026). H.H.H.W.S. has received funding from from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 777111 (Repotrial). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I+D+i 2013–2016, funded by ISCIII and FEDER. The DCEXS is a “Unidad de Excelencia María de Maeztu”, funded by the MINECO (ref: MDM-2014-0370)
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Changes in the free-energy landscape of p38α MAP kinase through its canonical activation and binding events as studied by enhanced molecular dynamics simulations

  • Kuzmanic, Antonija
  • Sutto, Ludovico
  • Saladino, Giorgio
  • Nebreda, Ángel R.
  • Gervasio, Francesco L.
  • Orozco, Modesto
p38α is a Ser/Thr protein kinase involved in a variety of cellular processes and pathological conditions, which makes it a promising pharmacological target. Although the activity of the enzyme is highly regulated, its molecular mechanism of activation remains largely unexplained, even after decades of research. By using state-of-the-art molecular dynamics simulations, we decipher the key elements of the complex molecular mechanism refined by evolution to allow for a fine tuning of p38α kinase activity. Our study describes for the first time the molecular effects of different regulators of the enzymatic activity, and provides an integrative picture of the activation mechanism that explains the seemingly contradictory X-ray and NMR data., AK was partly supported by the European Union Seventh Framework Programme (FP7/Marie Curie Actions/COFUND, no. 600404). FLG and GS acknowledge financial support from EPSRC (grant EP/M013898/1). ARN was supported by a grant from the European Commission (ERC, project ID: 294665). MO is an ICREA research fellow. MO acknowledges the support from two grants from the European Commission H2020 program (BioExcel project ID: 676559 and ELIXIR- Excellerate project ID: 675728) and the Spanish MINECO (BIO2015/64802-R).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

ResMarkerDB: a database of biomarkers of response to antibody therapy in breast and colorectal cancer

  • Pérez-Granado, Judith
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
The clinical efficacy of therapeutic monoclonal antibodies for breast and colorectal cancer has greatly contributed to the improvement of patients' outcomes by individualizing their treatments according to their genomic background. However, primary or acquired resistance to treatment reduces its efficacy. In this context, the identification of biomarkers predictive of drug response would support research and development of new alternative treatments. Biomarkers play a major role in the genomic revolution, supporting disease diagnosis and treatment decision-making. Currently, several molecular biomarkers of treatment response for breast and colorectal cancer have been described. However, information on these biomarkers is scattered across several resources, and needs to be identified, collected and properly integrated to be fully exploited to inform monitoring of drug response in patients. Therefore, there is a need of resources that offer biomarker data in a harmonized manner to the user to support the identification of actionable biomarkers of response to treatment in cancer. ResMarkerDB was developed as a comprehensive resource of biomarkers of drug response in colorectal and breast cancer. It integrates data of biomarkers of drug response from existing repositories, and new data extracted and curated from the literature (referred as ResCur). ResMarkerDB currently features 266 biomarkers of diverse nature. Twenty-five percent of these biomarkers are exclusive of ResMarkerDB. Furthermore, ResMarkerDB is one of the few resources offering non-coding DNA data in response to drug treatment. The database contains more than 500 biomarker-drug-tumour associations, covering more than 100 genes. ResMarkerDB provides a web interface to facilitate the exploration of the current knowledge of biomarkers of response in breast and colorectal cancer. It aims to enhance translational research efforts in identifying actionable biomarkers of drug response in cancer., Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional [grant numbers: PIE15/00008, CP10/00524, CPII16/00026]; Instituto de Salud Carlos III-Fondo Social Europeo [FI18/00034]; and the European Commission Horizon 2020 Programme 2014–2020 under grant agreements MedBioinformatics [grant number: 634143] and Elixir-Excelerate [grant number: 676559]. The Research Programme on Biomedical Informatics is a member of the Spanish National Bioinformatics Institute, Plataforma de Recursos Biomoleculares y Bioinformáticos-Instituto de Salud Carlos III [grant number: PT13/0001/0023], of the PE I + D + i 2013–2016, funded by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional. The Departamento de Ciencias Experimentales y de la Salud is a Unidad de Excelencia María de Maeztu, funded by the Ministerio de Economía y Competitividad (reference number: MDM-2014-0370).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Benchmarking post-GWAS analysis tools in major depression: Challenges and implications

  • Pérez-Granado, Judith
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
Our knowledge of complex disorders has increased in the last years thanks to the identification of genetic variants (GVs) significantly associated with disease phenotypes by genome-wide association studies (GWAS). However, we do not understand yet how these GVs functionally impact disease pathogenesis or their underlying biological mechanisms. Among the multiple post-GWAS methods available, fine-mapping and colocalization approaches are commonly used to identify causal GVs, meaning those with a biological effect on the trait, and their functional effects. Despite the variety of post-GWAS tools available, there is no guideline for method eligibility or validity, even though these methods work under different assumptions when accounting for linkage disequilibrium and integrating molecular annotation data. Moreover, there is no benchmarking of the available tools. In this context, we have applied two different fine-mapping and colocalization methods to the same GWAS on major depression (MD) and expression quantitative trait loci (eQTL) datasets. Our goal is to perform a systematic comparison of the results obtained by the different tools. To that end, we have evaluated their results at different levels: fine-mapped and colocalizing GVs, their target genes and tissue specificity according to gene expression information, as well as the biological processes in which they are involved. Our findings highlight the importance of fine-mapping as a key step for subsequent analysis. Notably, the colocalizing variants, altered genes and targeted tissues differed between methods, even regarding their biological implications. This contribution illustrates an important issue in post-GWAS analysis with relevant consequences on the use of GWAS results for elucidation of disease pathobiology, drug target prioritization and biomarker discovery., IMI2-JU resources which are composed of financial contributions from the European Union’s Horizon 2020 Research and Innovation Programme and EFPIA (GA: 116030 TransQST and GA: 777365 eTRANSAFE), and the EU H2020 Programme 2014–2020 (GA: 676559 Elixir-Excelerate); Project 001-P-001647—Valorisation of EGA for Industry and Society funded by the European Regional Development Fund (ERDF) and Generalitat de Catalunya; Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya (2017SGR00519), and the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), funded by ISCIII and ERDF (PRB2-ISCIII (PT13/0001/0023, of the PE I + D + i 2013–2016)). The MELIS is a ‘Unidad de Excelencia María de Maeztu’, funded by the MINECO (MDM-2014-0370). JP-G was supported by Instituto de Salud Carlos III-Fondo Social Europeo (FI18/00034). This statement is a requirement from our funding agencies and therefore has to be included in the Funding section.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Advances and applications in the quest for orthologs

  • Glover, Natasha
  • Dessimoz, Christophe
  • Ebersberger, Ingo
  • Forslund, Sofia K.
  • Gabaldón Estevan, Juan Antonio, 1973-
  • Huerta Cepas, Jaime
  • Martin, Maria-Jesus
  • Muffato, Matthieu
  • Patricio, Mateus
  • Pereira, Cecile
  • Sousa da Silva, Alan
  • Wang, Yan-Dong
  • Sonnhammer, Erik
  • Thomas, Paul D.
Gene families evolve by the processes of speciation (creating orthologs), gene duplication (paralogs), and horizontal gene transfer (xenologs), in addition to sequence divergence and gene loss. Orthologs in particular play an essential role in comparative genomics and phylogenomic analyses. With the continued sequencing of organisms across the tree of life, the data are available to reconstruct the unique evolutionary histories of tens of thousands of gene families. Accurate reconstruction of these histories, however, is a challenging computational problem, and the focus of the Quest for Orthologs Consortium. We review the recent advances and outstanding challenges in this field, as revealed at a symposium and meeting held at the University of Southern California in 2017. Key advances have been made both at the level of orthology algorithm development and with respect to coordination across the community of algorithm developers and orthology end-users. Applications spanned a broad range, including gene function prediction, phylostratigraphy, genome evolution, and phylogenomics. The meetings highlighted the increasing use of meta-analyses integrating results from multiple different algorithms, and discussed ongoing challenges in orthology inference as well as the next steps toward improvement and integration of orthology resources., We thank the Society for Molecular Biology and Evolution for supporting the SMBE-EGF Symposium, and the University of Southern California for supporting the QFO5 meeting. We wish to acknowledge the following support for attending the meetings and/or writing this manuscript: National Institutes of Health (grant HG002273 for P.D.T.; HG007822 for M.J.M. and A.S.d.S.; GM122480, HD085901, DK110520 for E.M.M.; GM123683 for C.M.), Wellcome Trust (grant WT108749/Z/15/Z for M.M. and M.P.), Swiss National Science Foundation (grant 150654 for C.D.), European Commission (contract 676559 for S.C.G.), Welch Foundation (grant F-1515 for E.M.M.), European Molecular Biology Laboratory (for M.J.M., M.M., M.P.), and National Bioscience Database Center and Japan Science and Technology Agency (for I.U.).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The European Genome-phenome Archive in 2021

  • Freeberg, Mallory Ann
  • Fromont, Lauren A.
  • D'Altri, Teresa, 1984-
  • Jene, Aina
  • Moldes, Mauricio
  • Ariosa, Roberto
  • Fernández-Orth, Dietmar
  • Haziza, Frédéric
  • Martinez Llobet, Oscar
  • Milla, Gemma
  • Rueda, Manuel
  • Singh, Babita, 1986-
  • Torre, Sabela de la
  • Uyan, Umuthan
  • Vasallo, Claudia
  • Guigó Serra, Roderic
  • Navarro i Cuartiellas, Arcadi, 1969-
  • Rambla de Argila, Jordi
The European Genome-phenome Archive (EGA - https://ega-archive.org/) is a resource for long term secure archiving of all types of potentially identifiable genetic, phenotypic, and clinical data resulting from biomedical research projects. Its mission is to foster hosted data reuse, enable reproducibility, and accelerate biomedical and translational research in line with the FAIR principles. Launched in 2008, the EGA has grown quickly, currently archiving over 4,500 studies from nearly one thousand institutions. The EGA operates a distributed data access model in which requests are made to the data controller, not to the EGA, therefore, the submitter keeps control on who has access to the data and under which conditions. Given the size and value of data hosted, the EGA is constantly improving its value chain, that is, how the EGA can contribute to enhancing the value of human health data by facilitating its submission, discovery, access, and distribution, as well as leading the design and implementation of standards and methods necessary to deliver the value chain. The EGA has become a key GA4GH Driver Project, leading multiple development efforts and implementing new standards and tools, and has been appointed as an ELIXIR Core Data Resource., Horizon 2020 Programme of the European Union [CORBEL [654248], ELIXIR-EXCELERATE [676559], Solve-RD [779257], EASI-Genomics [824110], EJP-RD [825575], CINECA [825775], EuCanCan [825835], EUCanshare [825903], ELIXIR-CONVERGE [871075]]; Wellcome Trust Global Alliance for Genomics and Health [201535/Z/16/Z]; UK Biobank; Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation [2017-171304 (5022)]; European Molecular Biology Laboratory (EMBL); LaCaixa Foundation [004745/008034]; [LCF/PR/CE20/50740008]. Funding for open access charge: LaCaixa Foundation [LCF/PR/CE20/50740008].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The DisGeNET cytoscape app: exploring and visualizing disease genomics data

  • Piñero González, Janet, 1977-
  • Saüch Pitarch, Josep
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
Thanks to the unbiased exploration of genomic variants at large scale, hundreds of thousands of disease-associated loci have been uncovered. In parallel, network-based approaches have proven to be essential to understand the molecular mechanisms underlying human diseases. The use of these approaches has been boosted by the abundance of information about disease associated genes and variants, high quality human interactomics data, and the emergence of new types of omics data. The DisGeNET Cytoscape App combines the capabilities of Cytoscape with those of DisGeNET, a knowledge platform based on a comprehensive catalogue of disease-associated genes and variants. The DisGeNET Cytoscape App contains functions to query, analyze, and visualize different network representations of the gene-disease and variant-disease associations available in DisGeNET. It supports a wide variety of applications through its query and filter functionalities, including the annotation of foreign networks generated by other apps or uploaded by the user. The new release of the DisGeNET Cytoscape App has been designed to support Cytoscape 3.x and incorporates novel distinctive features such as visualization and analysis of variant-disease networks, disease enrichment analysis for genes and variants, and analytic support through Cytoscape Automation. Moreover, the DisGeNET Cytoscape App features an API to access its core functionalities via the REST protocol fostering the development of reproducible and scalable analysis workflows based on DisGeNET data., IMI-JU resources of which are composed of financial contribution from the EU-FP7 [FP7/2007–2013] and EFPIA companies in kind contribution [116030 to TransQST, 777365 to eTRANSAFE], and the EU H2020 Programme 2014–2020 [676559 to Elixir-Excelerate.]; Project 001-P-001647 - Valorisation of EGA for Industry and Society funded by the European Regional Development Fund (ERDF) and Generalitat de Catalunya; Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya [2017SGR00519]. The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), funded by ISCIII and FEDER (PRB2-ISCIII [PT13/0001/0023, of the PE I + D + i 2013–2016]). The DCEXS is a ‘Unidad de Excelencia María de Maeztu’, funded by the MINECO [MDM-2014-0370]
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants

  • Piñero González, Janet, 1977-
  • Bravo Serrano, Àlex, 1984-
  • Queralt Rosinach, Núria
  • Gutiérrez Sacristán, Alba
  • Déu Pons, Jordi
  • Centeno, Emilio
  • García-García, Javier, 1982-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
The information about the genetic basis of human diseases lies at the heart of precision medicine and drug discovery. However, to realize its full potential to support these goals, several problems, such as fragmentation, heterogeneity, availability and different conceptualization of the data must be overcome. To provide the community with a resource free of these hurdles, we have developed DisGeNET (http://www.disgenet.org), one of the largest available collections of genes and variants involved in human diseases. DisGeNET integrates data from expert curated repositories, GWAS catalogues, animal models and the scientific literature. DisGeNET data are homogeneously annotated with controlled vocabularies and community-driven ontologies. Additionally, several original metrics are provided to assist the prioritization of genotype–phenotype relationships. The information is accessible through a web interface, a Cytoscape App, an RDF SPARQL endpoint, scripts in several programming languages and an R package. DisGeNET is a versatile platform that can be used for different research purposes including the investigation of the molecular underpinnings of specific human diseases and their comorbidities, the analysis of the properties of disease genes, the generation of hypothesis on drug therapeutic action and drug adverse effects, the validation of computationally predicted disease genes and the evaluation of text-mining methods performance., Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional [CP10/00524 and PI13/00082]; Innovative Medicines Initiative Joint Undertaking [Open PHACTs No. 115191]; resources of which are composed of financial contribution from the European Union's Seventh Framework Programme [FP7/2007-2013]; EFPIA companies’ in kind contribution; European Union Horizon 2020 Programme 2014-2020 [MedBioinformatics No. 634143 and Elixir-Excelerate No. 676559]. The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER. Funding for open access charge: Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional [PI13/00082].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Ten steps to get started in Genome Assembly and Annotation

  • Dominguez Del Angel, Victoria
  • Hjerde, Erik
  • Sterck, Lieven
  • Capella Gutiérrez, Salvador Jesús, 1985-
  • Notredame, Cedric
  • Vinnere Pettersson, Olga
  • Amselem, Joëlle
  • Bouri, Laurent
  • Bocs, Stephanie
  • Klopp, Christophe
  • Gibrat, Jean-François
  • Vlasova, Anna
  • Leskosek, Brane L.
  • Soler, Lucile
  • Binzer-Panchai, Mahesh
  • Lantz, Henrik
As a part of the ELIXIR-EXCELERATE efforts in capacity building, we present here 10 steps to facilitate researchers getting started in genome assembly and genome annotation. The guidelines given are broadly applicable, intended to be stable over time, and cover all aspects from start to finish of a general assembly and annotation project. Intrinsic properties of genomes are discussed, as is the importance of using high quality DNA. Different sequencing technologies and generally applicable workflows for genome assembly are also detailed. We cover structural and functional annotation and encourage readers to also annotate transposable elements, something that is often omitted from annotation workflows. The importance of data management is stressed, and we give advice on where to submit data and how to make your results Findable, Accessible, Interoperable, and Reusable (FAIR)., ELIXIR-EXCELERATE is funded by the European Commission within the Research Infrastructures Programme of Horizon 2020 [676559].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The functional impact of alternative splicing in cancer

  • Climente González, Héctor
  • Porta-Pardo, Eduard
  • Godzik, Adam
  • Eyras Jiménez, Eduardo
Alternative splicing changes are frequently observed in cancer and are starting to be recognized as important signatures for tumor progression and therapy. However, their functional impact and relevance to tumorigenesis remain mostly unknown. We carried out a systematic analysis to characterize the potential functional consequences of alternative splicing changes in thousands of tumor samples. This analysis revealed that a subset of alternative splicing changes affect protein domain families that are frequently mutated in tumors and potentially disrupt protein-protein interactions in cancer-related pathways. Moreover, there was a negative correlation between the number of these alternative splicing changes in a sample and the number of somatic mutations in drivers. We propose that a subset of the alternative splicing changes observed in tumors may represent independent oncogenic processes that could be relevant to explain the functional transformations in cancer, and some of them could potentially be considered alternative splicing drivers (AS drivers)., H.C.-G. and E.E. were supported by the MINECO and FEDER (BIO2014-52566-R), Consolider RNAREG (CSD2009-00080), AGAUR (SGR2014-1121), the European ITN Network RNP-Net (ID: 289007), and the Sandra Ibarra Foundation for Cancer (FSI2013). E.P.-P. and A.G. were supported by the SBP CC grant (P30 CA030199). All authors thank The Cancer Genome Atlas project for making their data publicly available. The Computational RNA Biology Group is part of the Research Programme on Biomedical Informatics (GRIB), which is a member of ELIXIR-Excelerate of the European Union Horizon 2020 Programme 2014-2020 (No. 676559) and of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023 of the PE I+D+I 2013-2016, funded by ISCIII and FEDER
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

comoRbidity: an R package for the systematic analysis of disease comorbidities

  • Gutiérrez Sacristán, Alba
  • Bravo Serrano, Àlex, 1984-
  • Giannoula, Alexia
  • Mayer, Miguel Ángel, 1960-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
MOTIVATION: The study of comorbidities is a major priority due to their impact on life expectancy, quality of life and healthcare cost. The availability of electronic health records (EHRs) for data mining offers the opportunity to discover disease associations and comorbidity patterns from the clinical history of patients gathered during routine medical care. This opens the need for analytical tools for detection of disease comorbidities, including the investigation of their underlying genetic basis. RESULTS: We present comoRbidity, an R package aimed at providing a systematic and comprehensive analysis of disease comorbidities from both the clinical and molecular perspectives. comoRbidity leverages from (i) user provided clinical data from EHR databases (the clinical comorbidity analysis) and (ii) genotype-phenotype information of the diseases under study (the molecular comorbidity analysis) for a comprehensive analysis of disease comorbidities. The clinical comorbidity analysis enables identifying significant disease comorbidities from clinical data, including sex and age stratification and temporal directionality analyses, while the molecular comorbidity analysis supports the generation of hypothesis on the underlying mechanisms of the disease comorbidities by exploring shared genes among disorders. The open-source comoRbidity package is a software tool aimed at expediting the integrative analysis of disease comorbidities by incorporating several analytical and visualization functions., The authors received support from ISCIII-FEDER (PI13/00082, CP10/00524, CPII16/00026), IMI-JU under grants agreements no. 115372 (EMIF), no. 115735 (iPiE), resources of which are composed of financial contribution from the EU-FP7 (FP7/2007-2013) and EFPIA companies in kind contribution and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (ElixirExcelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D+i 2013-2016, funded by ISCIII and FEDER. AGS acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the ‘María de Maeztu’ Programme for Units of Excellence in R&D (MDM-2014-0370).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Four simple recommendations to encourage best practices in research software

  • Jiménez, Rafael C.
  • Sanz, Ferran
  • Crouch, Steve
Scientific research relies on computer software, yet software is not always developed following practices that ensure its quality and sustainability. This manuscript does not aim to propose new software development best practices, but rather to provide simple recommendations that encourage the adoption of existing best practices. Software development best practices promote better quality software, and better quality software improves the reproducibility and reusability of research. These recommendations are designed around Open Source values, and provide practical suggestions that contribute to making research software and its source code more discoverable, reusable and transparent. This manuscript is aimed at developers, but also at organisations, projects, journals and funders that can increase the quality and sustainability of research software by encouraging the adoption of these recommendations., This work was partially supported by ELIXIR-EXCELERATE and CORBEL. ELIXIR-EXCELERATE and CORBEL are funded by the European Commission within the Research Infrastructures programme of Horizon 2020, grant agreement numbers 676559 and 654248. The European workshops were supported by ELIXIR and organised in collaboration with the Software Sustainability Institute and Netherlands eScience Center. The workshop in Australia was supported by EMBL-ABR via its main funders: The University of Melbourne and Bioplatforms Australia.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubut, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo, Francesca
  • Herranz Ors, Carmen, 1992-
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 and “Plataforma de Bioinformática” PT17/0009/0006 from the ISCIII, all co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1–2015–1 ELIXIR-EXCELERATE (ref. 676559) and EU FP7-People ITN Marie Curie Project (ref 316861). The article was previously published as a preprint: Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Kinza Rian, Francisco Salavert, Miguel Angel Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell Caballero, Joaquin Dopazo. 2018. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. bioRxiv https://doi.org/10.1101/367334.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The DisGeNET knowledge platform for disease genomics: 2019 update

  • Piñero González, Janet, 1977-
  • Ramírez Anguita, Juan Manuel
  • Saüch Pitarch, Josep
  • Ronzano, Francesco
  • Centeno, Emilio
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
One of the most pressing challenges in genomic medicine is to understand the role played by genetic variation in health and disease. Thanks to the exploration of genomic variants at large scale, hundreds of thousands of disease-associated loci have been uncovered. However, the identification of variants of clinical relevance is a significant challenge that requires comprehensive interrogation of previous knowledge and linkage to new experimental results. To assist in this complex task, we created DisGeNET (http://www.disgenet.org/), a knowledge management platform integrating and standardizing data about disease associated genes and variants from multiple sources, including the scientific literature. DisGeNET covers the full spectrum of human diseases as well as normal and abnormal traits. The current release covers more than 24 000 diseases and traits, 17 000 genes and 117 000 genomic variants. The latest developments of DisGeNET include new sources of data, novel data attributes and prioritization metrics, a redesigned web interface and recently launched APIs. Thanks to the data standardization, the combination of expert curated information with data automatically mined from the scientific literature, and a suite of tools for accessing its publicly available data, DisGeNET is an interoperable resource supporting a variety of applications in genomic medicine and drug R&D., SCIII-FEDER [PI13/00082, PI17/00230, CPII16/00026]; IMI-JU resources of which are composed of financial contribution from the EU-FP7 [FP7/2007–2013] and EFPIA companies in kind contribution [116030 to TransQST, 777365 to eTRANSAFE], and the EU H2020 Programme 2014–2020 [676559 to Elixir-Excelerate]; Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya [2017SGR00519]. The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), funded by ISCIII and FEDER (PRB2-ISCIII [PT13/0001/0023, of the PE I+D+i 2013–2016]). The DCEXS is a ‘Unidad de Excelencia María de Maeztu’, funded by the MINECO [MDM-2014-0370]. Funding for open access charge: Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya [2017SGR00519].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

PMut: A web-based tool for the annotation of pathological variants on proteins, 2017 update

  • López Ferrando, Víctor
  • Gazzo, Andrea M.
  • Cruz, Xavier de la
  • Orozco, Modesto
  • Gelpí, Josep Lluís
We present here a full update of the PMut predictor, active since 2005 and with a large acceptance in the field of predicting Mendelian pathological mutations. PMut internal engine has been renewed, and converted into a fully featured standalone training and prediction engine that not only powers PMut web portal, but that can generate custom predictors with alternative training sets or validation schemas. PMut Web portal allows the user to perform pathology predictions, to access a complete repository of pre-calculated predictions, and to generate and validate new predictors. The default predictor performs with good quality scores (MCC values of 0.61 on 10-fold cross validation, and 0.42 on a blind test with SwissVar 2016 mutations). The PMut portal is freely accessible at http://mmb.irbbarcelona.org/PMut. A complete help and tutorial is available at http://mmb.irbbarcelona.org/PMut/help., Spanish Ministry of Science [BIO2015-64802-R-32868, SEV-2015-0493, TIN2012-34557, TEC2015-67774-C2-2-R, SAF2016-80255-R]; Catalan Government [2014-SGR-134, 2014-SGR-1051]; Instituto de Salud Carlos III-Instituto Nacional de Bioinformática [INB; PT13/0001/0019, PT13/0001/0028]; European Union, H2020 programme [Elixir-Excelerate: 676559; BioExcel: 674728 and MuG: 676566]; La Caixa Foundation fellowship [to V.L.F.]. Funding for open access charge: European Union and Spanish Ministry of Science.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

An ensemble learning approach for modeling the systems biology of drug-induced injury

  • Aguirre Plans, Joaquim, 1993-
  • Piñero González, Janet, 1977-
  • Souza, Terezinha
  • Callegaro, Giulia
  • Kunnen, Steven J.
  • Sanz, Ferran
  • Fernández Fuentes, Narcís
  • Furlong, Laura I., 1971-
  • Guney, Emre
  • Oliva Miguel, Baldomero
Background: Drug-induced liver injury (DILI) is an adverse reaction caused by the intake of drugs of common use that produces liver damage. The impact of DILI is estimated to affect around 20 in 100,000 inhabitants worldwide each year. Despite being one of the main causes of liver failure, the pathophysiology and mechanisms of DILI are poorly understood. In the present study, we developed an ensemble learning approach based on different features (CMap gene expression, chemical structures, drug targets) to predict drugs that might cause DILI and gain a better understanding of the mechanisms linked to the adverse reaction. Results: We searched for gene signatures in CMap gene expression data by using two approaches: phenotype-gene associations data from DisGeNET, and a non-parametric test comparing gene expression of DILI-Concern and No-DILI-Concern drugs (as per DILIrank definitions). The average accuracy of the classifiers in both approaches was 69%. We used chemical structures as features, obtaining an accuracy of 65%. The combination of both types of features produced an accuracy around 63%, but improved the independent hold-out test up to 67%. The use of drug-target associations as feature obtained the best accuracy (70%) in the independent hold-out test. Conclusions: When using CMap gene expression data, searching for a specific gene signature among the landmark genes improves the quality of the classifiers, but it is still limited by the intrinsic noise of the dataset. When using chemical structures as a feature, the structural diversity of the known DILI-causing drugs hampers the prediction, which is a similar problem as for the use of gene expression information. The combination of both features did not improve the quality of the classifiers but increased the robustness as shown on independent hold-out tests. The use of drug-target associations as feature improved the prediction, specially the specificity, and the results were comparable to previous research studies., The authors received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreements TransQST and eTRANSAFE (refs: 116030, 777365). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA companies in kind contribution. The authors also received support from Spanish Ministry of Economy (MINECO, refs: BIO2017–85329-R (FEDER, EU), RYC-2015-17519) as well as EU H2020 Programme 2014–2020 under grant agreement No. 676559 (Elixir-Excelerate) and from Agència de Gestió D’ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR, ref.: 2017SGR01020). L.I.F. received support from ISCIII-FEDER (ref: CPII16/00026). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D + i 2013–2016, funded by ISCIII and FEDER. The DCEXS is a “Unidad de Excelencia María de Maeztu”, funded by the MINECO (ref: MDM-2014-0370). J.A.P. received support from the CAMDA Travel Fellowship.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Federated discovery and sharing of genomic data using Beacons

  • Fiume, Marc
  • Rambla de Argila, Jordi
  • Torre, Sabela de la
  • Scollen, Serena
M.F. and S.O.M.D. are supported by Genome Quebec, Genome Canada, the Government of Canada, and the Ministère de l’Économie, Innovation et Exportation du Québec (Can-SHARE grant 141210); S.O.M.D. is supported by the Canadian Institutes of Health Research (grants EP1-120608; EP2-120609); M.H. is supported by BD2K NIH/NCI 5U54HG007990-02; S. Scollen, S.V., M.B., I.L., J.T., S.U.-R., S.d.l.T., M.L., H.S. and the EGA are supported by ELIXIR, the research infrastructure for life-science data. This work was supported by ELIXIR-EXCELERATE, funded by the European Commission within the Research Infrastructures programme of Horizon 2020, grant agreement number 676559 (J.D.S., I.L.), the Wellcome Trust grant numbers WT201535/Z/16/Z (P.F.) and WT098051 (S.K., D.L., P.F.). A.J.B. is supported by the European Union FP7 Programme ‘EMIF’ IMI-JU grant no. 115372, and H2020 Programme ‘GCOF’ grant no. 643439
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Identifying temporal patterns in patient disease trajectories using dynamic time warping: A population-based study

  • Giannoula, Alexia
  • Gutiérrez Sacristán, Alba
  • Bravo Serrano, Àlex, 1984-
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
Time is a crucial parameter in the assessment of comorbidities in population-based studies, as it permits to identify more complex disease patterns apart from the pairwise disease associations. So far, it has been, either, completely ignored or only, taken into account by assessing the temporal directionality of identified comorbidity pairs. In this work, a novel time-analysis framework is presented for large-scale comorbidity studies. The disease-history vectors of patients of a regional Spanish health dataset are represented as time sequences of ordered disease diagnoses. Statistically significant pairwise disease associations are identified and their temporal directionality is assessed. Subsequently, an unsupervised clustering algorithm, based on Dynamic Time Warping, is applied on the common disease trajectories in order to group them according to the temporal patterns that they share. The proposed methodology for the temporal assessment of such trajectories could serve as the preliminary basis of a disease prediction system., We received support from ISCIII-FEDER (PI13/00082, CP10/00524, CPII16/00026), IMI-JU under grants agreements no. 115372 (EMIF), resources composed of financial contribution from the EU-FP7 (FP7/2007-2013) and EFPIA companies in kind contribution, and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D + i 2013-2016, funded by ISCIII and FEDER. Funding has been also received by the Marie-Curie UPFellowship Program.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Towards a European health research and innovation cloud (HRIC)

  • Aarestrup, Frank M.
  • Gut, Ivo Glynne
  • Sanz, Ferran
  • Van Oyen, Herman
The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) aims to provide the conditions necessary for building a secure, flexible, and decentralized digital health infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this environment should enable data sharing and analysis for health research across the EU, in compliance with data protection legislation while preserving the full trust of the participants. Such a HRIC should learn from and build on existing data infrastructures, integrate best practices, and focus on the concrete needs of the community in terms of technologies, governance, management, regulation, and ethics requirements. Here, we describe the vision and expected benefits of digital data sharing in health research activities and present a roadmap that fosters the opportunities while answering the challenges of implementing a HRIC. For this, we put forward five specific recommendations and action points to ensure that a European HRIC: i) is built on established standards and guidelines, providing cloud technologies through an open and decentralized infrastructure; ii) is developed and certified to the highest standards of interoperability and data security that can be trusted by all stakeholders; iii) is supported by a robust ethical and legal framework that is compliant with the EU General Data Protection Regulation (GDPR); iv) establishes a proper environment for the training of new generations of data and medical scientists; and v) stimulates research and innovation in transnational collaborations through public and private initiatives and partnerships funded by the EU through Horizon 2020 and Horizon Europe., The workshop participants received funding from the European Union Seventh Program for Research, Technological Development and Demonstration (FP7) and Horizon Research and Innovation Program (H2020) and other European Union programs under the following grant agreements: AETIONOMY (Developing an Aetiology-based Taxonomy of Human Disease—Approaches to Develop a New Taxonomy for Neurological Disorders, IMI-no115568), ANTI-SUPERBUG PCP (ANTISUPERBUG Precommercial Procurement, H2020-no688878), B-CAST (Breast CAncer Stratification understanding the determinants of risk and prognosis of molecular sub-types, H2020-no633784), BRIDGE Health (Bridging information and data generation for evidence-based health policy and research, H2020-no664691), CASyM (Coordinating Action Systems Medicine—Implementation of Systems Medicine across Europe, FP7-n°305033), CENTER-TBI (Collaborative European NeuroTrauma Effectiveness Research in TBI, FP7-no602150), CECM (Centre for New Methods in Computational Diagnostics and Personalized Therapy, H2020-no763734), COLOSSUS (Advancing a Precision Medicine Paradigm in Metastatic Colorectal Cancer: Systems based patient stratification solutions, H2020-no754923), COMPARE (COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe, H2020-no643476), CONNECARE (Personalized Connected Care for Complex Chronic Patients, H2020-no689802), CREATIVE (Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe, FP7-no602714), DEFORM (Define the global and financial impact of research misconduct H2020-no710246), ECCTR (European Cornea and Cell Transplant Registry, FP7-n°709723), E-COMPARED (European COMPARative Effectiveness Research on online Depression, FP7-no603098), ECRIN-IA (European Clinical Research Infrastructures Network- Integrating Activity, FP7-no284395), EHR4CR (Electronic Health Records Systems for Clinical Research, IMI-no115189) eInfraCentral (European E-infrastructures Services Gateway, H2020-no731049), ELIXIR (European Life-science Infrastructure for Biological Information, FP7-n°211601), ELIXIR-EXCELERATE (Fast track ELIXIR implementation and drive early user exploitation across the life sciences, H2020-no676559), eMEN (e-mental health innovation and transnational implementation platform North West Europe, H2020), EMIF (European Medical Information Framework, IMI-no115372), ERA PerMed (ERA-net Cofund in Personalized Medicine, H2020-no779282), eTRIKS (Delivering European Translational Information and Knowledge Management Services, IMI-1-no115446), EuroPOND (Data-driven models for progression of neurological diseases, H2020-n°666992), EurValve (Personalized Decision Support for Heart Valve disease, H2020-no689617), HBP SGA1/SGA2 (Human Brain Project specific grant agreements, H2020-n°720270/785907), ICT4DEPRESSION (User-friendly ICT tools to enhance self-management and effective treatment of depression in the EU, FP7-n°248778), ImpleMentAll (Towards evidence-based tailored implementation strategies for eHealth, H2020-no733025), INSTRUCT-ULTRA (Releasing the full potential of instruct to expand and consolidate infrastructure services for integrated structural life sciences research, H2020-no731005), MASTERMIND (Management of Mental Disorders through Advanced Technologies, CIP-no621000), MeDALL (Mechanisms of the Development of ALLergy, FP7-n°261357), MedBioinformatics (Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities, H2020-n°634143), MIDAS (Meaningful Integration of Data, Analytics and Services, H2020-no727721), MultipleMS (Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalized medicine, H2020-no733161), myPEBS (Randomized Comparison Of Risk-Stratified versus Standard Breast Cancer Screening European Women Aged 40–74, H2020-no755394), OpenAIRE-Advance (Advancing Open Scholarship, H2020-no777541), OpenMedicine (OpenMedicine, H2020-n°643796), PanCareSurFup (PanCare Childhood and Adolescent Cancer Survival Care and Follow-up Studies, FP7-n°257505), PIONEER (Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope, H2020-IMI-2-n°777492), PREPARE (Platform for European Preparedness Against (Re-)emerging Epidemics, FP7-n°602525), Regions4PerMed (Interregional coordination for a deep and fast uptake of personalized health, H2020-no825812), RD-CONNECT (An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research, FP7-no305344), Solve-RD (Solving the unsolved Rare Diseases, H2020-no779257), SPIDIA4P (SPIDIA for Personalized Medicine-Standardization of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine, H2020-no733112), SYSCID (A Systems medicine approach to chronic inflammatory disease, H2020-no733100), SysCLAD (Systems prediction of Chronic Allograft Dysfunction, FP7-n°305457), SYSCOL (Systems Biology of Colorectal Cancer, FP7-no258236), SysMedPD (Systems Medicine of Mitochondrial Parkinson’s Disease, H2020-n°668738), U-BIOPRED (Unbiased BIOmarkers for the PREDiction of respiratory disease outcomes, IMI-n°115010), VPH-share (Virtual Physiological Human: Sharing for Healthcare—A Research Environment, FP7-n°269978).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Uncovering disease mechanisms through network biology in the era of next generation sequencing.

  • Piñero González, Janet, 1977-
  • Berenstein, Ariel José
  • González-Pérez, Abel
  • Chernomoretz, Ariel
  • Furlong, Laura I., 1971-
Characterizing the behavior of disease genes in the context of biological networks has the potential to shed light on disease mechanisms, and to reveal both new candidate disease genes and therapeutic targets. Previous studies addressing the network properties of disease genes have produced contradictory results. Here we have explored the causes of these discrepancies and assessed the relationship between the network roles of disease genes and their tolerance to deleterious germline variants in human populations leveraging on: the abundance of interactome resources, a comprehensive catalog of disease genes and exome variation data. We found that the most salient network features of disease genes are driven by cancer genes and that genes related to different types of diseases play network roles whose centrality is inversely correlated to their tolerance to likely deleterious germline mutations. This proved to be a multiscale signature, including global, mesoscopic and local network centrality features. Cancer driver genes, the most sensitive to deleterious variants, occupy the most central positions, followed by dominant disease genes and then by recessive disease genes, which are tolerant to variants and isolated within their network modules., We received support from UBACyT (20020130100582BA) and MinCyT (PICT2014-2701), ISCIII-FEDER (PI13/00082, CP10/00524), IMI-JU under grants agreements n° 115002 (eTOX), n° 115191 (Open PHACTS)], n° 115372 (EMIF) and n° 115735 (iPiE), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution, and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB). A.G.-P. is supported by a Ramon y Cajal scholarship funded by the Spanish Ministry of Economy. The authors would like to thank the Exome Aggregation Consortium and the groups that provided exome variant data for comparison. A full list of contributing groups can be found at http://exac.broadinstitute.org/about.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

A comparison of mechanistic signaling pathway activity analysis methods

  • Amadoz, Alicia
  • Hidalgo, Marta R.
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Understanding the aspects of cell functionality that account for disease mechanisms or drug modes of action is a main challenge for precision medicine. Classical gene-based approaches ignore the modular nature of most human traits, whereas conventional pathway enrichment approaches produce only illustrative results of limited practical utility. Recently, a family of new methods has emerged that change the focus from the whole pathways to the definition of elementary subpathways within them that have any mechanistic significance and to the study of their activities. Thus, mechanistic pathway activity (MPA) methods constitute a new paradigm that allows recoding poorly informative genomic measurements into cell activity quantitative values and relate them to phenotypes. Here we provide a review on the MPA methods available and explain their contribution to systems medicine approaches for addressing challenges in the diagnostic and treatment of complex diseases., This work was supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 from the ISCIII, both co-funded with European Regional Development Funds (ERDF), and EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE (ref. 676559).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes

  • Gutiérrez Sacristán, Alba
  • Hernández Ferrer, Carles
  • González, Juan Ramón
  • Furlong, Laura I., 1971-
MOTIVATION: Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts. RESULTS: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders. AVAILABILITY AND IMPLEMENTATION: The package is implemented in R and is available under MIT license from Bioconductor (http://bioconductor.org/packages/release/bioc/html/psygenet2r.html)., This work was supported by ISCIII-FEDER [PI13/00082, CP10/00524, CPII16/00026], MICINN [MTM2015-68140-R], IMI-JU under grants agreements no. 115191 (Open PHACTS), no. 115372 (EMIF), no. 115735 (iPiE), resources of which are composed of financial contribution from the EU-FP7 [FP7/2007–2013] and EFPIA companies in kind contribution, and the EU H2020 Programme 2014–2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of ELIXIR-ES and the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D+i 2013-2016, funded by ISCIII and FEDER. A.G.S. acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the ‘María de Maeztu’ Programme for Units of Excellence in R&D [MDM-2014-0370].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Functional genomics analysis to disentangle the role of genetic variants in major depression

  • Pérez-Granado, Judith
  • Piñero González, Janet, 1977-
  • Medina-Rivera, Alejandra
  • Furlong, Laura I., 1971-
Understanding the molecular basis of major depression is critical for identifying new potential biomarkers and drug targets to alleviate its burden on society. Leveraging available GWAS data and functional genomic tools to assess regulatory variation could help explain the role of major depression-associated genetic variants in disease pathogenesis. We have conducted a fine-mapping analysis of genetic variants associated with major depression and applied a pipeline focused on gene expression regulation by using two complementary approaches: cis-eQTL colocalization analysis and alteration of transcription factor binding sites. The fine-mapping process uncovered putative causally associated variants whose proximal genes were linked with major depression pathophysiology. Four colocalizing genetic variants altered the expression of five genes, highlighting the role of SLC12A5 in neuronal chlorine homeostasis and MYRF in nervous system myelination and oligodendrocyte differentiation. The transcription factor binding analysis revealed the potential role of rs62259947 in modulating P4HTM expression by altering the YY1 binding site, altogether regulating hypoxia response. Overall, our pipeline could prioritize putative causal genetic variants in major depression. More importantly, it can be applied when only index genetic variants are available. Finally, the presented approach enabled the proposal of mechanistic hypotheses of these genetic variants and their role in disease pathogenesis., IMI2-JU resources which are composed of financial contributions from the European Union’s Horizon 2020 Research and Innovation Programme and EFPIA [GA: 116030 TransQST and GA: 777365 eTRANSAFE], and the EU H2020 Programme 2014–2020 [GA: 676559 Elixir-Excelerate]; Project 001-P-001647—Valorisation of EGA for Industry and Society funded by the European Regional Development Fund (ERDF) and Generalitat de Catalunya; Agència de Gestió d’Ajuts Universitaris i de Recerca Generalitat de Catalunya [2017SGR00519], and the Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), funded by ISCIII and ERDF (PRB2-ISCIII [PT13/0001/0023, of the PE I + D + i 2013–2016]). The MELIS is a ‘Unidad de Excelencia María de Maeztu’, funded by the MINECO [MDM-2014-0370]. AMR was supported by CONACYT-FORDECYT-PRONACES grant no. [11311], and Programa de Apoyo a Proyectos de Investigación e Innovación Tecnológica–Universidad Nacional Autónoma de México (PAPIIT-UNAM) grant nos. IA203021. JPG was supported by Instituto de Salud Carlos III-Fondo Social Europeo [FI18/00034]; Instituto de Salud Carlos III [MV20]. This work reflects only the author’s view and that the IMI2-JU is not responsible for any use that may be made of the information it contains.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases

  • Laurie, Steven, 1973-
  • Piscia, Davide
  • Matalonga, Leslie
  • Corvò, Alberto
  • Fernández Callejo, Marcos
  • Garcia-Linares, Carles
  • Hernandez-Ferrer, Carles, 1987-
  • Luengo, Cristina
  • Martínez, Inés
  • Papakonstantinou, Anastasios
  • Picó-Amador, Daniel
  • Protasio, Joan
  • Tonda, Raúl
  • Bayés, Mònica
  • Bullich, Gemma
  • Camps-Puchadas, Jordi
  • Paramonov, Ida
  • Trotta, Jean-Remi
  • Pérez Jurado, Luis Alberto
  • Rambla de Argila, Jordi
  • Gut, Ivo Glynne
  • Lochmüller, Hanns
  • Beltran, Sergi
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the wide adoption of next-generation sequencing. However, many cases remain undiagnosed even after exome or genome analysis, because the methods used missed the molecular cause in a known gene, or a novel causative gene could not be identified and/or confirmed. To address these challenges, the RD-Connect Genome-Phenome Analysis Platform (GPAP) facilitates the collation, discovery, sharing, and analysis of standardized genome-phenome data within a collaborative environment. Authorized clinicians and researchers submit pseudonymised phenotypic profiles encoded using the Human Phenotype Ontology, and raw genomic data which is processed through a standardized pipeline. After an optional embargo period, the data are shared with other platform users, with the objective that similar cases in the system and queries from peers may help diagnose the case. Additionally, the platform enables bidirectional discovery of similar cases in other databases from the Matchmaker Exchange network. To facilitate genome-phenome analysis and interpretation by clinical researchers, the RD-Connect GPAP provides a powerful user-friendly interface and leverages tens of information sources. As a result, the resource has already helped diagnose hundreds of rare disease patients and discover new disease causing genes., We acknowledge the support of the developers of PhenoTips, which was used in the past by RD-Connect and NeurOmics as the primary tool to collate phenotypic data. We would also like to thank the leaders and members of the Instituto Nacional de Bioinformática (INB) and ELIXIR for their support and collaboration throughout the years. RD-Connect (RD-Connect, an integrated platform connecting registries, biobanks, and clinical bioinformatics) received funding from the Seventh Framework (FP7) Programme of the European Union under grant agreement No 305444. Data were analyzed using the RD-Connect GPAP, which received funding from EU projects Solve-RD, EJP-RD (grant numbers H2020 779257, H2020 825575), Instituto de Salud Carlos III (Grant numbers PT13/0001/0044, PT17/0009/0019; Instituto Nacional de Bioinformática, INB), ELIXIR-EXCELERATE (Grant number EU H2020 #676559) and ELIXIR Implementation Studies (Remote real-time visualization of human rare disease genomics data (RD-Connect) stored at the EGA ELIXIR. 2017-2018; ELIXIR IT-2017-INTEGRATION, Rare Disease Infrastructure ELIXIR, 2019-2020 and the Beacon ELIXIR, 2019-2021). The RD-Connect GPAP has leveraged developments funded through project VEIS (001-P-001647 co-financed by the European Regional Development Fund of the European Union in the framework of the Operational Program FEDER of Catalonia 2014-2020 with the support of the Secretaria d'Universitats i Recerca del Departament d'Empresa i Coneixement de la Generalitat de Catalunya) and URD-Cat (PERIS SLT002/16/00174, Departament de Salut, Generalitat de Catalunya). The research leading to these results has received funding from Consequitur (Newton Fund UK/Turkey, MR/N027302/1), BBMRI-LPC (EU FP7 #313010), NeurOmics (EU FP7 #305121), the Economic Development Department of the Navarra Government (Grant number 001114112017), the European Reference Network for Rare Neurological Diseases (Project ID number 739510) and NIH, National Institute of Child Health and Human Development (1R01HD103805-01). We acknowledge the support of the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Program/Generalitat de Catalunya. We also acknowledge the support of the Generalitat de Catalunya through Departament de Salut and Departament d'Empresa i Coneixement and Co-financing by the Spanish Ministry of Economy, Industry and Competitiveness (MEIC) with funds from the European Regional Development Fund (ERDF) corresponding to the 2014-2020 Smart Growth Operating Program. HL receives support from the Canadian Institutes of Health Research (Foundation Grant FDN-167281), the Canadian Institutes of Health Research and Muscular Dystrophy Canada (Network Catalyst Grant for NMD4C), the Canada Foundation for Innovation (CFI-JELF 38412), and the Canada Research Chairs program (Canada Research Chair in Neuromuscular Genomics and Health, 950-232279).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Registered access: authorizing data access

  • Dyke, Stephanie O. M.
  • De Argila, Jordi Rambla
  • Flicek, Paul
The Global Alliance for Genomics and Health (GA4GH) proposes a data access policy model-"registered access"-to increase and improve access to data requiring an agreement to basic terms and conditions, such as the use of DNA sequence and health data in research. A registered access policy would enable a range of categories of users to gain access, starting with researchers and clinical care professionals. It would also facilitate general use and reuse of data but within the bounds of consent restrictions and other ethical obligations. In piloting registered access with the Scientific Demonstration data sharing projects of GA4GH, we provide additional ethics, policy and technical guidance to facilitate the implementation of this access model in an international setting., SOMD is supported by the Canadian Institutes of Health Research (EP1-120608; EP1-120609; CEE-151618), Genome Quebec, Genome Canada, the Government of Canada, the Ministère de l’Économie, Innovation et Exportation du Québec (Can-SHARE grant 141210), and the Canada Research Chair in Law and Medicine. ML, IL, JT, and TN are supported by the ELIXIR, the research infrastructure for life-science data, and the H2020 ELIXIR-EXCELERATE grant 676559. IL and GK are supported by the European Molecular Biology Laboratory; MS by Research Foundation Flanders (FWO); MH by NIH/NHGRI 5U41HG002371-15; SW by NIH/NHGRI R00HG008175; S Beck by the National Institute for Health Research UCLH Biomedical Research Centre (BRC369/CN/SB/101310); S Brenner by NIH/NHGRI U41 HG007346; BMK by the Canada Research Chair in Law and Medicine; and PF by WT201535/Z/16/Z and the European Molecular Biology Laboratory.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Nucleosome Dynamics: a new tool for the dynamic analysis of nucleosome positioning

  • Buitrago, Diana
  • Codó, Laia
  • Illa, Ricard
  • Jorge, Pau de
  • Battistini, Federica
  • Flores, Oscar
  • Bayarri, Genis
  • Royo, Romina
  • Pino, Marc del
  • Heath, Simon
  • Hospital, Adam
  • Gelpí, Josep Lluís
  • Brun-Heath, Isabelle
  • Orozco, Modesto
We present Nucleosome Dynamics, a suite of programs integrated into a virtual research environment and created to define nucleosome architecture and dynamics from noisy experimental data. The package allows both the definition of nucleosome architectures and the detection of changes in nucleosomal organization due to changes in cellular conditions. Results are displayed in the context of genomic information thanks to different visualizers and browsers, allowing the user a holistic, multidimensional view of the genome/transcriptome. The package shows good performance for both locating equilibrium nucleosome architecture and nucleosome dynamics and provides abundant useful information in several test cases, where experimental data on nucleosome position (and for some cases expression level) have been collected for cells under different external conditions (cell cycle phase, yeast metabolic cycle progression, changes in nutrients or difference in MNase digestion level). Nucleosome Dynamics is a free software and is provided under several distribution models., M.O. is an ICREA (Institució Catalana de Recerca i Estudis Avancats) academia researcher; Spanish Ministry of Science [RTI2018-096704-B-100]; Catalan Government [2017-SGR-134]; Instituto de Salud Carlos III–Instituto Nacional de Bioinformática, the European Union's Horizon 2020 research and innovation program, and the Biomolecular and Bioinformatics Resources Platform [ISCIII PT 17/0009/0007 co-funded by the Fondo Europeo de Desarrollo Regional FEDER; Grants Elixir-Excelerate: 676559 and BioExcel2: 823830; ERC:812850; MuG-676566]; MINECO Severo Ochoa Award of Excellence from the Government of Spain (awarded to IRB Barcelona). Funding for open access charge: Spanish Ministry of Science [RTI2018-096704-B-100].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The discovery potential of RNA processing profiles

  • Pagès Pinós, Amadís
  • Dotu, Ivan
  • Pallarès Albanell, Joan, 1988-
  • Martí Puig, Eulàlia
  • Guigó Serra, Roderic
  • Eyras Jiménez, Eduardo
Small non-coding RNAs (sncRNAs) are highly abundant molecules that regulate essential cellular processes and are classified according to sequence and structure. Here we argue that read profiles from size-selected RNA sequencing capture the post-transcriptional processing specific to each RNA family, thereby providing functional information independently of sequence and structure. We developed SeRPeNT, a new computational method that exploits reproducibility across replicates and uses dynamic time-warping and density-based clustering algorithms to identify, characterize and compare sncRNAs by harnessing the power of read profiles. We applied SeRPeNT to: (i) generate an extended human annotation with 671 new sncRNAs from known classes and 131 from new potential classes, (ii) show pervasive differential processing of sncRNAs between cell compartments and (iii) predict new molecules with miRNA-like behaviour from snoRNA, tRNA and long non-coding RNA precursors, potentially dependent on the miRNA biogenesis pathway. Furthermore, we validated experimentally four predicted novel non-coding RNAs: a miRNA, a snoRNA-derived miRNA, a processed tRNA and a new uncharacterized sncRNA. SeRPeNT facilitates fast and accurate discovery and characterization of sncRNAs at an unprecedented scale. SeRPeNT code is available under the MIT license at https://github.com/comprna/SeRPeNT., MINECO (to E.E., A.P.); FEDER [BIO2014-52566-R to E.E., A.P.]; Consolider RNAREG [CSD2009-00080 to E.E., A.P.]; AGAUR [SGR2014-1121 to E.E., A.P.]; European ITN Network RNP-Net [ID:289007 to E.E., A.P.]; Sandra Ibarra Foundation for Cancer [FSI2013 to E.E., A.P.]; MINECO [BIO2011-26205 to R.G., A.P., SAF2014-60551-R to E.M., J.P.A.]; National Human Genome Research Institute of the National Institutes of Health [U54HG007004 to R.G., A.P.]; MINECO Centro de Excelencia Severo Ochoa 2013-2017 [SEV-2012-0208 to R.G., A.P.]; Research Programme on Biomedical Informatics (GRIB), which is member of ELIXIR-Excelerate of the European Union Horizon 2020 Programme 2014-2020 [676559 to E.E., A.P., I.D.]; ELIXIR-Excelerate, European Union Horizon 2020 Spanish National Bioinformatics Institute (INB) [PT13/0001/0023 to E.E., A.P., I.D.]. Funding for open access charge: European ITN Network RNP-Net [ID:289007] and MINECO-FEDER [BIO2014-52566-R].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Text mining and expert curation to develop a database on psychiatric diseases and their genes

  • Gutiérrez Sacristán, Alba
  • Bravo Serrano, Àlex, 1984-
  • Portero Tresserra, Marta
  • Valverde Granados, Olga
  • Leis Machín, Angela 1974-
  • Mayer, Miguel Ángel, 1960-
  • Warnault, Vincent
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
Psychiatric disorders constitute one of the main causes of disability worldwide. During the past years, considerable research has been conducted on the genetic architecture of such diseases, although little understanding of their etiology has been achieved. The difficulty to access up-to-date, relevant genotype-phenotype information has hampered the application of this wealth of knowledge to translational research and clinical practice in order to improve diagnosis and treatment of psychiatric patients. PsyGeNET (http://www.psygenet.org/) has been developed with the aim of supporting research on the genetic architecture of psychiatric diseases, by providing integrated and structured accessibility to their genotype-phenotype association data, together with analysis and visualization tools. In this article, we describe the protocol developed for the sustainable update of this knowledge resource. It includes the recruitment of a team of domain experts in order to perform the curation of the data extracted by text mining. Annotation guidelines and a web-based annotation tool were developed to support the curators' tasks. A curation workflow was designed including a pilot phase and two rounds of curation and analysis phases. Negative evidence from the literature on gene-disease associ- ations (GDAs) was taken into account in the curation process. We report the results of the application of this workflow to the curation of GDAs for PsyGeNET, including the analysis of the inter-annotator agreement and suggest this model as a suitable approach for the sustainable development and update of knowledge resources. Database URL: http://www.psygenet.org. PsyGeNET corpus: http://www.psygenet.org/ds/PsyGeNET/results/psygenetCorpus.tar, We received support from ISCIII-FEDER (PI13/00082, CP10/00524, CPII16/00026), IMI-JU under grants agreements no. 115191 (Open PHACTS)] and no. 115372 (EMIF), resources of which are composed of financial contribution from the EU-FP7 (FP7/2007-2013) and EFPIA companies in kind contribution, and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D+i 2013-2016, funded by ISCIII and FEDER. MRA, SMR and MCBG are supported RD16/0017/0007; OV, FF and MT are supported by RD16/0017/0010; and AS and FJP are supported by RD16/0017/0001, by Instituto de Salud Carlos III, Red de Trastornos Adictivos (RTA-Retics-ISCIII). AGS acknowledges financial support from the Spanish Ministry of Economy and Competitiveness, through the 'María de Maeztu' Programme for Units of Excellence in R&D (MDM-2014-0370). Funding for open access: EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns.

  • Digles, Daniela
  • Queralt Rosinach, Núria
  • Furlong, Laura I., 1971-
  • Jacoby, Edgar
Phenotypic screening is in a renaissance phase and is expected by many academic and industry leaders to accelerate the discovery of new drugs for new biology. Given that phenotypic screening is per definition target agnostic, the emphasis of in silico and in vitro follow-up work is on the exploration of possible molecular mechanisms and efficacy targets underlying the biological processes interrogated by the phenotypic screening experiments. Herein, we present six exemplar computational protocols for the interpretation of cellular phenotypic screens based on the integration of compound, target, pathway, and disease data established by the IMI Open PHACTS project. The protocols annotate phenotypic hit lists and allow follow-up experiments and mechanistic conclusions. The annotations included are from ChEMBL, ChEBI, GO, WikiPathways and DisGeNET. Also provided are protocols which select from the IUPHAR/BPS Guide to PHARMACOLOGY interaction file selective compounds to probe potential targets and a correlation robot which systematically aims to identify an overlap of active compounds in both the phenotypic as well as any kinase assay. The protocols are applied to a phenotypic pre-lamin A/C splicing assay selected from the ChEMBL database to illustrate the process. The computational protocols make use of the Open PHACTS API and data and are built within the Pipeline Pilot and KNIME workflow tools., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115191, resources of which are composed of financial contributions from the EU's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in-kind contribution. L. I. F. received support from ISCIII-FEDER (PI13/00082, CP10/00524) and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome

  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Background: Despite the progress in neuroblastoma therapies the mortality of high-risk patients is still high (40–50%) and the molecular basis of the disease remains poorly known. Recently, a mathematical model was used to demonstrate that the network regulating stress signaling by the c-Jun N-terminal kinase pathway played a crucial role in survival of patients with neuroblastoma irrespective of their MYCN amplification status. This demonstrates the enormous potential of computational models of biological modules for the discovery of underlying molecular mechanisms of diseases. Results: Since signaling is known to be highly relevant in cancer, we have used a computational model of the whole cell signaling network to understand the molecular determinants of bad prognostic in neuroblastoma. Our model produced a comprehensive view of the molecular mechanisms of neuroblastoma tumorigenesis and progression. Conclusion: We have also shown how the activity of signaling circuits can be considered a reliable model-based prognostic biomarker. Reviewers: This article was reviewed by Tim Beissbarth, Wenzhong Xiao and Joanna Polanska. For the full reviews, please go to the Reviewers’ comments section.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set

  • Del Toro, N.
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
  • Porras, P.
  • IMEx Consortium Curators
The current wealth of genomic variation data identified at nucleotide level presents the challenge of understanding by which mechanisms amino acid variation affects cellular processes. These effects may manifest as distinct phenotypic differences between individuals or result in the development of disease. Physical interactions between molecules are the linking steps underlying most, if not all, cellular processes. Understanding the effects that sequence variation has on a molecule's interactions is a key step towards connecting mechanistic characterization of nonsynonymous variation to phenotype. We present an open access resource created over 14 years by IMEx database curators, featuring 28,000 annotations describing the effect of small sequence changes on physical protein interactions. We describe how this resource was built, the formats in which the data is provided and offer a descriptive analysis of the data set. The data set is publicly available through the IntAct website and is enhanced with every monthly release., The IntAct database and EMBL-EBI-based authors received funding from EMBL core funding and Open Targets (grant agreement OTAR-044). The DIP database is funded by NIH grant R01GM123126. MINT received support from ERC grant ‘DEPTH project of the European Research Council (grant agreement 322749)’. The British Heart Foundation-University College of London (BHF-UCL) curation team is funded with the British Heart Foundation grant RG/13/5/30112. UniProt curation activities at EMBL-EBI and the Swiss Institute of Bioinformatics are funded by the National Eye Institute, National Human Genome Research Institute, National Heart, Lung, and Blood Institute, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of General Medical Sciences, and National Institute of Mental Health of the National Institutes of Health under Award Number [U24HG007822], National Human Genome Research Institute under Award Numbers [U41HG007822 and U41HG002273], and the National Institute of General Medical Sciences under Award Numbers [R01GM080646, P20GM103446 and U01GM120953] (the content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health); Swiss Federal Government through the State Secretariat for Education, Research and Innovation; and aforementioned British Heart Foundation grants and EMBL core funding. DisGeNET is supported with EU-FP7 funds from ISCIII-FEDER (CP10/00524, CPII16/00026), IMI-JU (grant agreement no. 116030, TransQST) and EFPIA companies in kind contribution, and the EU H2020 Programme 2014-2020 (grant agreements no. 634143, MedBioinformatics and no. 676559, Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I+D+i 2013-2016, funded by ISCIII and FEDER. The DCEXS is a ‘Unidad de Excelencia María de Maeztu’, funded by the MINECO (ref: MDM-2014-0370). I.J. and group supported in part by Krembil Foundation, Ontario Research Fund (#34876), and Canada Foundation for Innovation (CFI #225404, #30865, #33536). The authors would like to thank Marco Galardini, Luz García-Alonso, Denes Turei and Martin Krallinger for valuable discussions when designing the data set output format; Iain Moal for providing key information about SKEMPI 2.0; Danish Memon for his help pre-processing cBioPortal data; and Luz García-Alonso as the creator of the Python scripts we used to parse UniProt mutagenesis annotations.
Repisalud
Publication Artículo científico (JournalArticle)

The RD-Connect Registry & Biobank Finder: a tool for sharing aggregated data and metadata among rare disease researchers

  • Gainotti, Sabina
  • Torreri, Paola
  • Wang, Chiuhui Mary
  • Reihs, Robert
  • Mueller, Heimo
  • Heslop, Emma
  • Roos, Marco
  • Badowska, Dorota Mazena
  • de Paulis, Federico
  • Kodra, Yllka
  • Carta, Claudio
  • Lopez-Martin, Estrella
  • Miller, Vanessa Rangel
  • Filocamo, Mirella
  • Mora, Marina
  • Thompson, Mark
  • Rubinstein, Yaffa
  • Posada De la Paz, Manuel
  • Monaco, Lucia
  • Lochmüller, Hanns
  • Taruscio, Domenica
In rare disease (RD) research, there is a huge need to systematically collect biomaterials, phenotypic, and genomic data in a standardized way and to make them findable, accessible, interoperable and reusable (FAIR). RD-Connect is a 6 years global infrastructure project initiated in November 2012 that links genomic data with patient registries, biobanks, and clinical bioinformatics tools to create a central research resource for RDs. Here, we present RD-Connect Registry & Biobank Finder, a tool that helps RD researchers to find RD biobanks and registries and provide information on the availability and accessibility of content in each database. The finder concentrates information that is currently sparse on different repositories (inventories, websites, scientific journals, technical reports, etc.), including aggregated data and metadata from participating databases. Aggregated data provided by the finder, if appropriately checked, can be used by researchers who are trying to estimate the prevalence of a RD, to organize a clinical trial on a RD, or to estimate the volume of patients seen by different clinical centers. The finder is also a portal to other RD-Connect tools, providing a link to the RD-Connect Sample Catalogue, a large inventory of RD biological samples available in participating biobanks for RD research. There are several kinds of users and potential uses for the RD-Connect Registry & Biobank Finder, including researchers collaborating with academia and the industry, dealing with the questions of basic, translational, and/or clinical research. As of November 2017, the finder is populated with aggregated data for 222 registries and 21 biobanks.
Repisalud
Publication Artículo científico (JournalArticle)

The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases

  • Laurie, Steven
  • Piscia, Davide
  • Matalonga, Leslie
  • Corvó, Alberto
  • Fernández-Callejo, Marcos
  • Garcia-Linares, Carles
  • Hernández-Ferrer, Carles
  • Luengo, Cristina
  • Martínez, Inés
  • Papakonstantinou, Anastasios
  • Picó-Amador, Daniel
  • Protasio, Joan
  • Thompson, Rachel
  • Tonda, Raul
  • Bayés, Mònica
  • Bullich, Gemma
  • Camps-Puchadas, Jordi
  • Paramonov, Ida
  • Trotta, Jean-Rémi
  • Alonso, Angel
  • Attimonelli, Marcella
  • Béroud, Christophe
  • Bros-Facer, Virginie
  • Buske, Orion J
  • Cañada-Pallarés, Andrés
  • Fernández, José M
  • Hansson, Mats G
  • Horvath, Rita
  • Jacobsen, Julius O B
  • Kaliyaperumal, Rajaram
  • Lair-Préterre, Séverine
  • Licata, Luana
  • Lopes, Pedro
  • Lopez-Martin, Estrella
  • Mascalzoni, Deborah
  • Monaco, Lucia
  • Pérez-Jurado, Luis Alberto
  • Posada De la Paz, Manuel
  • Rambla, Jordi
  • Rath, Ana
  • Riess, Olaf
  • Robinson, Peter N
  • Salgado, David
  • Smedley, Damian
  • Spalding, Dylan
  • 't Hoen, Peter A C
  • Töpf, Ana
  • Zaharieva, Irina
  • Graessner, Holm
  • Gut, Ivo G
  • Lochmüller, Hanns
  • Beltran, Sergi
Rare disease patients are more likely to receive a rapid molecular diagnosis nowadays thanks to the wide adoption of next-generation sequencing. However, many cases remain undiagnosed even after exome or genome analysis, because the methods used missed the molecular cause in a known gene, or a novel causative gene could not be identified and/or confirmed. To address these challenges, the RD-Connect Genome-Phenome Analysis Platform (GPAP) facilitates the collation, discovery, sharing, and analysis of standardized genome-phenome data within a collaborative environment. Authorized clinicians and researchers submit pseudonymised phenotypic profiles encoded using the Human Phenotype Ontology, and raw genomic data which is processed through a standardized pipeline. After an optional embargo period, the data are shared with other platform users, with the objective that similar cases in the system and queries from peers may help diagnose the case. Additionally, the platform enables bidirectional discovery of similar cases in other databases from the Matchmaker Exchange network. To facilitate genome-phenome analysis and interpretation by clinical researchers, the RD-Connect GPAP provides a powerful user-friendly interface and leverages tens of information sources. As a result, the resource has already helped diagnose hundreds of rare disease patients and discover new disease causing genes.
Digibug. Repositorio Institucional de la Universidad de Granada
Publication Artículo científico (JournalArticle)

Phylogenetic Analysis of the 2020 West Nile Virus (WNV) Outbreak in Andalusia (Spain)

  • Casimiro Soriguer, Carlos S.
  • Pedrosa Corral, Irene
  • Guillot Sulay, Vicente
  • Martínez González, Luis Javier
  • Navarro Marí, José María
  • Sanbonmatsu Gámez, Sara
This research was funded by grants PT17/0009/0006 from the ISCIII, co-funded by the European Regional Development Fund (ERDF) as well as H2020 "ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences" (GA 676559)., During recent decades West Nile Virus (WNV) outbreaks have continuously occurred in the Mediterranean area. In August 2020 a new WNV outbreak affected 71 people with meningoencephalitis in Andalusia and six more cases were detected in Extremadura (south-west of Spain), causing a total of eight deaths. The whole genomes of four viruses were obtained and phylogenetically analyzed in the context of recent outbreaks. The Andalusian viral samples belonged to lineage 1 and were relatively similar to those of previous outbreaks which occurred in the Mediterranean region. Here we present a detailed analysis of the outbreak, including an extensive phylogenetic study. As part on this effort, we implemented a local Nextstrain server, which has become a constituent piece of regional epidemiological surveillance, wherein forthcoming genomes of environmental samples or, eventually, future outbreaks, will be included., Instituto de Salud Carlos III PT17/0009/0006, European Commission, H2020 "ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences" 676559
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

BIGNASim: A NoSQL database structure and analysis portal for nucleic acids simulation data

  • Hospital Gasch, Adam
  • Andrio, Pau
  • Cugnasco, Cesare
  • Codo, Laia
  • Becerra, Yolanda
  • Dans, Pablo D.
  • Battistini, Federica
  • Torres, Jordi
  • Goñi Macià, Josep Ramon
  • Orozco López, Modesto
  • Gelpí Buchaca, Josep Lluís
Molecular dynamics simulation (MD) is, just behind genomics, the bioinformatics tool that generates the largest amounts of data, and that is using the largest amount of CPU time in supercomputing centres. MD trajectories are obtained after months of calculations, analysed in situ, and in practice forgotten. Several projects to generate stable trajectory databases have been developed for proteins, but no equivalence exists in the nucleic acids world. We present here a novel database system to store MD trajectories and analyses of nucleic acids. The initial data set available consists mainly of the benchmark of the new molecular dynamics force-field, parmBSC1. It contains 156 simulations, with over 120s of total simulation time. A deposition protocol is available to accept the submission of new trajectory data. The database is based on the combination of two NoSQL engines, Cassandra for storing trajectories and MongoDB to store analysis results and simulation metadata. The analyses available include backbone geometries, helical analysis, NMR observables and a variety of mechanical analyses. Individual trajectories and combined metatrajectories can be downloaded from the portal. The system is accessible through http://mmb.irbbarcelona.org/BIGNASim/. Supplementary Material is also available on-line at http://mmb.irbbarcelona.org/BIGNASim/SuppMaterial/.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Nucleosome Dynamics: A new tool for the dynamic analysis of nucleosome positioning

  • Buitrago Ospina, Diana Camila
  • Codó Tarraubella, Laia
  • Illa Pujagut, Ricard
  • Jorge, Pau de
  • Flores Guri, Oscar
  • Battistini, Federica
  • Bayarri, Genís
  • Royo, Romina
  • Del Pino, Marc
  • Heath, Simon C.
  • Hospital Gasch, Adam
  • Gelpí Buchaca, Josep Lluís
  • Brun Heath, Isabelle
  • Orozco López, Modesto
We present Nucleosome Dynamics, a suite of programs integrated into a virtual research environment and created to define nucleosome architecture and dynamics from noisy experimental data. The package allows both the definition of nucleosome architectures and the detection of changes in nucleosomal organization due to changes in cellular conditions. Results are displayed in the context of genomic information thanks to different visualizers and browsers, allowing the user a holistic, multidimensional view of the genome/transcriptome. The package shows good performance for both locating equilibrium nucleosome architecture and nucleosome dynamics and provides abundant useful information in several test cases, where experimental data on nucleosome position (and for some cases expression level) have been collected for cells under different external conditions (cell cycle phase, yeast metabolic cycle progression, changes in nutrients or difference in MNase digestion level). Nucleosome Dynamics is a free software and is provided under several distribution models.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

The multiple roles of waters in protein solvation

  • Hospital Gasch, Adam
  • Candotti, Michela
  • Gelpí Buchaca, Josep Lluís
  • Orozco López, Modesto
Extensive molecular dynamics (MD) simulations have been used to characterize the multiple roles of water in solvating different types of proteins under different environmental conditions. We analyzed a small set of proteins, representative of the most prevalent meta-folds under native conditions, in the presence of crowding agents, and at high temperature with or without high concentration of urea. We considered also a protein in the unfolded state as characterized by NMR and atomistic MD simulations. Our results outline the main characteristics of the hydration environment of proteins and illustrate the dramatic plasticity of water, and its chameleonic ability to stabilize proteins under a variety of conditions.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

PMut. A web-based tool for the annotation of pathological variants on proteins, 2017 update

  • López Ferrando, Víctor
  • Gazzo, Andrea
  • Cruz, Xavier de la
  • Orozco López, Modesto
  • Gelpí Buchaca, Josep Lluís
We present here a full update of the PMut predictor, active since 2005 and with a large acceptance in the field of predicting Mendelian pathological mutations. PMut internal engine has been renewed, and converted into a fully featured standalone training and prediction engine that not only powers PMut web portal, but that can generate custom predictors with alternative training sets or validation schemas. PMut Web portal allows the user to perform pathology predictions, to access a complete repository of pre-calculated predictions, and to generate and validate new predictors. The default predictor performs with good quality scores (MCC values of 0.61 on 10-fold cross validation, and 0.42 on a blind test with SwissVar 2016 mutations). The PMut portal is freely accessible at http://mmb.irbbarcelona.org/PMut. A complete help and tutorial is available at http://mmb.irbbarcelona.org/PMut/help.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubuk, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo González, Francesca
  • Herranz, Carmen
  • Carbonell Caballero, José
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

BioExcel Building Blocks, a software library for interoperable biomolecular simulation workflows.

  • Andrio, Pau
  • Hospital Gasch, Adam
  • Conejero, Javier
  • Jordá, Luis
  • Del Pino, Marc
  • Codo, Laia
  • Soiland-Reyes, Stian
  • Goble, Carole
  • Lezzi, Daniele
  • Badia, Rosa M.
  • Orozco López, Modesto
  • Gelpí Buchaca, Josep Lluís
In the recent years, the improvement of software and hardware performance has made biomolecular simulations a mature tool for the study of biological processes. Simulation length and the size and complexity of the analyzed systems make simulations both complementary and compatible with other bioinformatics disciplines. However, the characteristics of the software packages used for simulation have prevented the adoption of the technologies accepted in other bioinformatics fields like automated deployment systems, workflow orchestration, or the use of software containers. We present here a comprehensive exercise to bring biomolecular simulations to the "bioinformatics way of working". The exercise has led to the development of the BioExcel Building Blocks (BioBB) library. BioBB's are built as Python wrappers to provide an interoperable architecture. BioBB's have been integrated in a chain of usual software management tools to generate data ontologies, documentation, installation packages, software containers and ways of integration with workflow managers, that make them usable in most computational environments.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Four simple recommendations to encourage best practices in research software

  • Jiménez, Rafael C.
  • Kuzak, Mateusz
  • Alhamdoosh, Monther
  • Barker, Michelle
  • Batut, Bérénice
  • Borg, Mikael
  • Capella Gutiérrez, Salvador Jesús, 1985-
  • Chue Hong, Neil
  • Cook, Martin
  • Corpas, Manuel
  • Flannery, Madison
  • Garcia, Leyla
  • Gelpí Buchaca, Josep Lluís
  • Gladman, Simon
  • Goble, Carole
  • González-Ferreiro, Montserrat
  • Gonzalez-Beltran, Alejandra
  • Griffin, Philippa C. 
  • Grüning, Björn
  • Hagberg, Jonas 
  • Holub, Petr
  • Hooft, Rob W. W.
  • Ison, Jon
  • Katz, Daniel S.
  • Leskosek, Brane
  • López Gómez, Federico
  • Oliveira, Luis J.
  • Mellor, David
  • Mosbergen, Rowland
  • Mulder, Nicola
  • Perez-Riverol, Yasset
  • Pergl, Robert
  • Pichler, Horst
  • Pope, Bernard
  • Sanz, Ferran
  • Schneider, Maria V.
  • Stodden, Victoria
  • Suchecki, Radosław
  • Svobodová Vařeková, Rarka
Scientific research relies on computer software, yet software is not always developed following practices that ensure its quality and sustainability. This manuscript does not aim to propose new software development best practices, but rather to provide simple recommendations that encourage the adoption of existing best practices. Software development best practices promote better quality software, and better quality software improves the reproducibility and reusability of research. These recommendations are designed around Open Source values, and provide practical suggestions that contribute to making research software and its source code more discoverable, reusable and transparent. This manuscript is aimed at developers, but also at organisations, projects, journals and funders that can increase the quality and sustainability of research software by encouraging the adoption of these recommendations.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

The bio.tools registry of software tools and data resources for the life sciences

  • Ison, Jon
  • Ienasescu, Hans
  • Chmura, Piotr
  • Rydza, Emil
  • Ménager, Hérve
  • Kalas, Matús
  • Schwämmle, Veit
  • Grüning, Björn
  • Beard, Niall
  • Lopez, Rodrigo
  • Duvaud, Severine
  • Stockinger, Heinz
  • Persson, Bengt
  • Vařeková, Radka Svobodová
  • Racek, Tomás
  • Vondrásek, Jiri
  • Peterson, Hedi
  • Salumets, Ahto
  • Jonassen, Inge
  • Hooft, Rob W. W.
  • Nyrönen, Tommi
  • Valencia, Alfonso
  • Capella Gutiérrez, Salvador Jesús, 1985-
  • Gelpí Buchaca, Josep Lluís
  • Zambelli, Federico
  • Savakis, Babis
  • Leskosek, Brane
  • Rapacki, Kristoffer
  • Blanchet, Christophe
  • Jiménez, Rafael C.
  • Oliveira, Arlindo
  • Vriend, Gert
  • Collin, Olivier
  • van Helden, Jacques
  • Løngreen, Peter
  • Brunak, Sören
Bioinformaticians and biologists rely increasingly upon workflows for the flexible utilization of the many life science tools that are needed to optimally convert data into knowledge. We outline a pan-European enterprise to provide a catalogue (https://bio.tools) of tools and databases that can be used in these workflows. bio.tools not only lists where to find resources, but also provides a wide variety of practical information.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

The discovery potential of RNA processing profiles

  • Pagès, Amadís
  • Dotu, Ivan
  • Pallarès Albanell, Joan
  • Martí Puig, Eulàlia
  • Guigó Serra, Roderic
  • Eyras, Eduardo
Small non-coding RNAs (sncRNAs) are highly abundant molecules that regulate essential cellular processes and are classified according to sequence and structure. Here we argue that read profiles from size-selected RNA sequencing capture the post-transcriptional processing specific to each RNA family, thereby providing functional information independently of sequence and structure. We developed SeRPeNT, a new computational method that exploits reproducibility across replicates and uses dynamic time-warping and density-based clustering algorithms to identify, characterize and compare sncRNAs by harnessing the power of read profiles. We applied SeRPeNT to: (i) generate an extended human annotation with 671 new sncRNAs from known classes and 131 from new potential classes, (ii) show pervasive differential processing of sncRNAs between cell compartments and (iii) predict new molecules with miRNA-like behaviour from snoRNA, tRNA and long non-coding RNA precursors, potentially dependent on the miRNA biogenesis pathway. Furthermore, we validated experimentally four predicted novel non-coding RNAs: a miRNA, a snoRNA-derived miRNA, a processed tRNA and a new uncharacterized sncRNA. SeRPeNT facilitates fast and accurate discovery and characterization of sncRNAs at an unprecedented scale. SeRPeNT code is available under the MIT license at https://github.com/comprna/SeRPeNT.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes

  • Gutiérrez Sacristán, Alba
  • Hernández Ferrer, Carles
  • González, Juan Ramón
  • Furlong, Laura I.
Motivation: Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts. Results: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders. Availability: The package is implemented in R and is available under MIT license from Bioconductor ( http://bioconductor.org/packages/release/bioc/html/psygenet2r.html ). Supplementary information: Supplementary data are available at Bioinformatics online.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A community proposal to integrate proteomics activities in ELIXIR

  • Vizcaíno, Juan Antonio
  • Walzer, Mathias
  • Jiménez, Rafael C.
  • Corrales, Fernando J.
  • Kohlbacher, Oliver
Opinion Article.-- et al., Computational approaches have been major drivers behind the progress of proteomics in recent years. The aim of this white paper is to provide a framework for integrating computational proteomics into ELIXIR in the near future, and thus to broaden the portfolio of omics technologies supported by this European distributed infrastructure. This white paper is the direct result of a strategy meeting on 'The Future of Proteomics in ELIXIR' that took place in March 2017 in Tübingen (Germany), and involved representatives of eleven ELIXIR nodes. These discussions led to a list of priority areas in computational proteomics that would complement existing activities and close gaps in the portfolio of tools and services offered by ELIXIR so far. We provide some suggestions on how these activities could be integrated into ELIXIR's existing platforms, and how it could lead to a new ELIXIR use case in proteomics. We also highlight connections to the related field of metabolomics, where similar activities are ongoing. This white paper could thus serve as a starting point for the integration of computational proteomics into ELIXIR. Over the next few months we will be working closely with all stakeholders involved, and in particular with other representatives of the proteomics community, to further refine this paper., The meeting was funded by funds provided by the ELIXIR Central Hub (supported by EU H2020 Research Infrastructures). This activity is included in the ELIXIR Implementation Project entitled ‘Mining the Proteome: Enabling Automated Processing and Analysis of Large-Scale Proteomics Data’., We acknowledge support by the CSIC Open Access Publication Initiative through its Unit of Information Resources for Research (URICI)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Using Scipion for stream image processing at Cryo-EM facilities

  • Gómez-Blanco, Josué
  • Rosa-Trevín, J. M. de la
  • Marabini, Roberto
  • Caño, Laura del
  • Jiménez, A.
  • Martínez, Marta
  • Melero, Roberto
  • Majtner, T.
  • Maluenda, D.
  • Mota, J.
  • Rancel, Y.
  • Ramírez-Aportela, Erney
  • Vilas, J. L.
  • Carroni, M.
  • Fleischmann, S.
  • Lindahl, E.
  • Ashton, A. W.
  • Basham, M.
  • Clare, D. K.
  • Savage, K.
  • Siebert, C. A.
  • Sharov, G. G.
  • Sorzano, Carlos Óscar S.
  • Conesa Mingo, Pablo
  • Carazo, José M.
Three dimensional electron microscopy is becoming a very data-intensive field in which vast amounts of experimental images are acquired at high speed. To manage such large-scale projects, we had previously developed a modular workflow system called Scipion (de la Rosa-Trevín et al., 2016). We present here a major extension of Scipion that allows processing of EM images while the data is being acquired. This approach helps to detect problems at early stages, saves computing time and provides users with a detailed evaluation of the data quality before the acquisition is finished. At present, Scipion has been deployed and is in production mode in seven Cryo-EM facilities throughout the world., Spanish Ministry of Economy and Competitiveness through Grants BIO2016-76400R(AEI/FEDER, UE) and AEI/FEDER BFU 2016 74868P, the Comunidad Autónoma de Madrid through Grant: S2017/BMD-3817, European Union (EU) and Horizon 2020 through grant Corbel (INFRADEV-1-2014-1, Proposal: 654248). The “Knut & Alice Wallenberg Foundation”, and “A Pilot Facility development grant from Science for Life Laboratory”. European Union (EU) and Horizon 2020 through grant EOSCpilot (INFRADEV-04-2016, Proposal: 739563).This work used the EGI Infrastructure and is co-funded by the EGIEngage project (Horizon 2020) under Grant No. 654142. European Union (EU) and Horizon 2020 through grant West-Life (EINFRA-2015-1, Proposal: 675858) European Union (EU) and Horizon 2020 through grant Elixir - EXCELERATE (INFRADEV-3-2015, Proposal: 676559) European Union (EU) and Horizon 2020 through grant iNEXT (INFRAIA-1-2014-2015, Proposal: 653706)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DNA specificities modulate the binding of human transcription factor A to mitochondrial DNA control region

  • Cuppari, Anna
  • Fernández-Millán, Pablo
  • Battistini, Federica
  • Tarrés-Soler, Aleix
  • Lyonnais, Sébastien
  • Iruela, Guillermo
  • Ruiz-López, Elena
  • Enciso, Yuliana
  • Rubio-Cosials, Anna
  • Prohens, Rafel
  • Pons, Miquel
  • Alfonso, Carlos
  • Tóth, Katalin
  • Rivas, Germán
  • Orozco, Modesto
  • Solà, Maria
© The Author(s) 2019., Human mitochondrial DNA (h-mtDNA) codes for 13 subunits of the oxidative phosphorylation pathway, the essential route that produces ATP. H-mtDNA transcription and replication depends on the transcription factor TFAM, which also maintains and compacts this genome. It is well-established that TFAM activates the mtDNA promoters LSP and HSP1 at the mtDNA control region where DNA regulatory elements cluster. Previous studies identified still uncharacterized, additional binding sites at the control region downstream from and slightly similar to LSP, namely sequences X and Y (Site-X and Site-Y) (Fisher et al., Cell 50, pp 247–258, 1987). Here, we explore TFAM binding at these two sites and compare them to LSP by multiple experimental and in silico methods. Our results show that TFAM binding is strongly modulated by the sequence-dependent properties of Site-X, Site-Y and LSP. The high binding versatility of Site-Y or the considerable stiffness of Site-X tune TFAM interactions. In addition, we show that increase in TFAM/DNA complex concentration induces multimerization, which at a very high concentration triggers disruption of preformed complexes. Therefore, our results suggest that mtDNA sequences induce non-uniform TFAM binding and, consequently, direct an uneven distribution of TFAM aggregation sites during the essential process of mtDNA compaction., Spanish Ministry of Science, Innovation and Universities, MINECO [BFU2012-33516, BFU2015-70645-R, RTI2018-101015-B-100 to M.S; BIO2015-64802-R, BFU2014-61670-EXP and BFU2014-52864-R to M.O., BIO2016-78006R to M.P.) Generalitat de Catalunya (2014-SGR-997 and 2017-SGR-1192 to M.S.; 2014-SGR-134 to M.O.), the Instituto de Salud Carlos III-Instituto Nacional de Bioinformática; the European Union (FP7-HEALTH-2010-261460, FP7-PEOPLE-2011-290246, FP7-HEALTH-2012-306029-2 to M.S.; H2020-EINFRA-2015-676556 to M.O.). The Biomolecular and Bioinformatics Resources Platform (ISCIII PT 13/000/0030 co-funded by the Fondo Europeo de Desarrollo Regional [FEDER]) [grants Elixir-Excelerate: 676559; BioExcel2:823830 and MuG: 676566] to M.O. P.F.-M. was awarded with FPI fellowship from MINECO, A.R.C. a JAE fellowship from Spanish Research Council (CSIC), an A. T-S. an FPU from Ministry of Education, Professional Formation (MEFP). A.T.-S. is doing his PhD thesis under the frame of the Doctorate Program Biochemistry, Molecular Biology and Biomedicine of the Autonomous University of Barcelona. The Structural Biology Unit at IBMB-CSIC is a “Maria de Maeztu” Unit of Excellence awarded by MINECO [MDM-2014-0435]. IRB Barcelona is the recipient of a Severo Ochoa Award of Excellence from MINECO. M.O. is an ICREA Academia researcher. Funding for open access charge: Spanish Ministry of Innovation, Science and Universities, formerly Spanish Ministry of Economy and Competitiveness [BFU2015-70645-R].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Mechanistic Models of Signaling Pathways Reveal the Drug Action Mechanisms behind Gender-Specific Gene Expression for Cancer Treatments

  • Çubuk, Cankut
  • Can, Fatma E.
  • Peña-Chilet, María
  • Dopazo, Joaquín
This article belongs to the Special Issue Targeting Signal Transduction Pathways and Non-coding RNAs as Potential Therapy in Cancer and Aging., Despite the existence of differences in gene expression across numerous genes between males and females having been known for a long time, these have been mostly ignored in many studies, including drug development and its therapeutic use. In fact, the consequences of such differences over the disease mechanisms or the drug action mechanisms are completely unknown. Here we applied mechanistic mathematical models of signaling activity to reveal the ultimate functional consequences that gender-specific gene expression activities have over cell functionality and fate. Moreover, we also used the mechanistic modeling framework to simulate the drug interventions and unravel how drug action mechanisms are affected by gender-specific differential gene expression. Interestingly, some cancers have many biological processes significantly affected by these gender-specific differences (e.g., bladder or head and neck carcinomas), while others (e.g., glioblastoma or rectum cancer) are almost insensitive to them. We found that many of these gender-specific differences affect cancer-specific pathways or in physiological signaling pathways, also involved in cancer origin and development. Finally, mechanistic models have the potential to be used for finding alternative therapeutic interventions on the pathways targeted by the drug, which lead to similar results compensating the downstream consequences of gender-specific differences in gene expression., This work is supported by grants SAF2017-88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT17/0009/0006 from the ISCIII, both co-funded with European Regional Development Funds (ERDF) as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network "Machine Learning Frontiers in Precision Medicine" (MLFPM) (GA 813533) and “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

SMN1 copy-number and sequence variant analysis from next-generation sequencing data

  • López-López, Daniel
  • Loucera, Carlos
  • Carmona, Rosario
  • Aquino, Virginia
  • Salgado-Garrido, Josefa
  • Pasalodos, Sara
  • Miranda, María
  • Alonso, Ángel
  • Dopazo, Joaquín
© 2020 The Authors., Spinal muscular atrophy (SMA) is a severe neuromuscular autosomal recessive disorder affecting 1/10,000 live births. Most SMA patients present homozygous deletion of SMN1, while the vast majority of SMA carriers present only a single SMN1 copy. The sequence similarity between SMN1 and SMN2, and the complexity of the SMN locus makes the estimation of the SMN1 copy-number by next-generation sequencing (NGS) very difficult. Here, we present SMAca, the first python tool to detect SMA carriers and estimate the absolute SMN1 copy-number using NGS data. Moreover, SMAca takes advantage of the knowledge of certain variants specific to SMN1 duplication to also identify silent carriers. This tool has been validated with a cohort of 326 samples from the Navarra 1000 Genomes Project (NAGEN1000). SMAca was developed with a focus on execution speed and easy installation. This combination makes it especially suitable to be integrated into production NGS pipelines. Source code and documentation are available at https://www.github.com/babelomics/SMAca., This study is supported by grants SAF2017‐88908‐R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de RecursosBiomoleculares y Bioinformáticos” PT17/0009/0006 from the ISCIII, both cofunded with European Regional Development Funds as well as H2020 Programme of the European Union grants Marie Curie Innovative Training Network “Machine Learning Frontiers in Precision Medicine” (GA 813533) and “ELIXIR‐EXCELERATE fast‐track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

BIPSPI: a method for the prediction of Partner-Specific Protein-Protein Interfaces

  • Sánchez-García, Rubén
  • Sorzano, Carlos Óscar S.
  • Carazo, José M.
  • Segura, Joan
© The Author(s) 2018., [Motivation]: Protein–Protein Interactions (PPI) are essentials for most cellular processes and thus, unveiling how proteins interact is a crucial question that can be better understood by identifying which residues are responsible for the interaction. Computational approaches are orders of magnitude cheaper and faster than experimental ones, leading to proliferation of multiple methods aimed to predict which residues belong to the interface of an interaction. [Results]: We present BIPSPI, a new machine learning-based method for the prediction of partner-specific PPI sites. Contrary to most binding site prediction methods, the proposed approach takes into account a pair of interacting proteins rather than a single one in order to predict partner-specific binding sites. BIPSPI has been trained employing sequence-based and structural features from both protein partners of each complex compiled in the Protein–Protein Docking Benchmark version 5.0 and in an additional set independently compiled. Also, a version trained only on sequences has been developed. The performance of our approach has been assessed by a leave-one-out cross-validation over different benchmarks, outperforming state-of-the-art methods., Instituto de Salud Carlos III, project number PT13/0001/0009 and PT17/0009/0010 funding the Spanish National Institute of Bioinformatics. The Spanish Ministry of Economy and Competitiveness through Grants AIC-A-2011-0638, BIO2013-44647-R, BIO2016-76400-R (AEI/FEDER, UE), the ‘Comunidad Auto´noma de Madrid’ through Grant: B2017/BMD-3817. Horizon 2020 through Grant CORBEL (INFRADEV-1-2014-1—Proposal: 654248), ELIXIR-EXCELERATE (INFRADEV-1-2015-1—Proposal: 676559) and West-Life (EINFRA-2015-1, Proposal: 675858). J. Segura is recipient of a ‘Juan de la Cierva’ fellowship and R. Sanchez-Garcia is recipient of a FPU fellowship.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Validation of electron microscopy initial models via small angle X-ray scattering curves

  • Jiménez, Amaya
  • Jonic, Slavica
  • Majtner, T.
  • Otón, Joaquín
  • Vilas, J. L.
  • Maluenda, D.
  • Mota, J.
  • Ramírez-Aportela, Erney
  • Martínez, Marta
  • Rancel, Y.
  • Segura, Joan
  • Sánchez-García, Rubén
  • Melero, Roberto
  • Caño, Laura del
  • Conesa Mingo, Pablo
  • Skjaerven, Lars
  • Marabini, Roberto
  • Carazo, José M.
  • Sorzano, Carlos Óscar S.
[Motivation]: Cryo electron microscopy (EM) is currently one of the main tools to reveal the structural information of biological macromolecules. The re-construction of three-dimensional (3D) maps is typically carried out following an iterative process that requires an initial estimation of the 3D map to be refined in subsequent steps. Therefore, its determination is key in the quality of the final results, and there are cases in which it is still an open issue in single particle analysis (SPA). Small angle X-ray scattering (SAXS) is a well-known technique applied to structural biology. It is useful from small nanostructures up to macromolecular ensembles for its ability to obtain low resolution information of the biological sample measuring its X-ray scattering curve. These curves, together with further analysis, are able to yield information on the sizes, shapes and structures of the analyzed particles. [Results]: In this paper, we show how the low resolution structural information revealed by SAXS is very useful for the validation of EM initial 3D models in SPA, helping the following refinement process to obtain more accurate 3D structures. For this purpose, we approximate the initial map by pseudo-atoms and predict the SAXS curve expected for this pseudo-atomic structure. The match between the predicted and experimental SAXS curves is considered as a good sign of the correctness of the EM initial map., This work was supported by the Spanish Ministry of Economy and Competitiveness through Grants BIO2016-76400-R(AEI/FEDER, UE), Comunidad Autonoma de Madrid through Grant: S2017/BMD-3817, Instituto de Salud Carlos III, PT13/0001/0009, PT17/0009/0010 and European Union (EU) and Horizon 2020 through Grants: Elixir—EXCELERATE (INFRADEV-3-2015, Proposal: 676559), iNEXT (INFRAIA-1-2014-2015, Proposal: 653706) and INSTRUCT—ULTRA (INFRADEV-03-2016-2017, Proposal: 731005).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A versatile workflow to integrate RNA-seq genomic and transcriptomic data into mechanistic models of signaling pathways

  • Garrido-Rodriguez, Martín
  • López-López, Daniel
  • Ortuño, Francisco M.
  • Peña-Chilet, María
  • Muñoz, Eduardo
  • Calzado, Marco A.
  • Dopazo, Joaquín
This is a PLOS Computational Biology Software paper., [Abstract] MIGNON is a workflow for the analysis of RNA-Seq experiments, which not only efficiently manages the estimation of gene expression levels from raw sequencing reads, but also calls genomic variants present in the transcripts analyzed. Moreover, this is the first workflow that provides a framework for the integration of transcriptomic and genomic data based on a mechanistic model of signaling pathway activities that allows a detailed biological interpretation of the results, including a comprehensive functional profiling of cell activity. MIGNON covers the whole process, from reads to signaling circuit activity estimations, using state-of-the-art tools, it is easy to use and it is deployable in different computational environments, allowing an optimized use of the resources available., [Author summary] Currently, RNA massive sequencing RNA-seq is the most extensively used technique for gene expression profiling in a single assay. The output of RNA-seq experiments contains millions of sequences, generated from cDNA libraries produced by the retro-transcription of RNA samples, that need to be processed by computational methods to be transformed into meaningful biological information. Thus, a number of bioinformatic workflows and pipelines have been proposed to produce different types of gene expression measurements, including in some cases, functional annotations to facilitate biological interpretation. While most pipelines focus exclusively on transcriptional data, the ultimate activity of the resulting gene product also depends critically on its integrity. Although traditional hybridization-based transcriptomics methodologies (microarrays) miss this information, RNA-seq data also contains information on variants present in the transcripts that can affect the function of the gene product, which is systematically ignored by current RNA-seq pipelines. MIGNON is the first workflow able to perform an integrative analysis of transcriptomic and genomic data in the proper functional context, provided by a mechanistic model of signaling pathway activity, making thus the most of the information contained in RNA-Seq data. MIGNON is easy to use and to deploy and may become a valuable asset in fields such as personalized medicine., JD has received these grants: SAF2017-88908-R from the Ministerio de Economía y Competitividad and PT17/0009/0006 from the Instituto de Salud Carlos III, as well as an FP7 People Marie-Curie Actions 813533 and and Horizon 2020 Framework Programme 676559., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CSVS, a crowdsourcing database of the Spanish population genetic variability

  • Peña-Chilet, María
  • Roldán, Gema
  • Pérez-Florido, Javier
  • Ortuño, Francisco M.
  • Carmona, Rosario
  • Aquino, Virginia
  • López-López, Daniel
  • Loucera, Carlos
  • Fernández-Rueda, José L.
  • Gallego, Asunción
  • García-García, Francisco
  • González-Neira, Anna
  • Pita, Guillermo
  • Núñez-Torres, Rocío
  • Santoyo-López, Javier
  • Ayuso, Carmen
  • Mínguez, Pablo
  • Ávila-Fernández, Almudena
  • Cortón, Marta
  • Moreno-Pelayo, Miguel Ángel
  • Morin, Matías
  • Gallego-Martinez, Álvaro
  • López-Escamez, José A.
  • Borrego, Salud
  • Antiñolo, Guillermo
  • Amigo, Jorge
  • Salgado-Garrido, Josefa
  • Pasalodos-Sánchez, Sara
  • Morte, Beatriz
  • Spanish Exome Crowdsourcing Consortium
  • Carracedo, Ángel
  • Alonso, Ángel
  • Dopazo, Joaquín
The knowledge of the genetic variability of the local population is of utmost importance in personalized medicine and has been revealed as a critical factor for the discovery of new disease variants. Here, we present the Collaborative Spanish Variability Server (CSVS), which currently contains more than 2000 genomes and exomes of unrelated Spanish individuals. This database has been generated in a collaborative crowdsourcing effort collecting sequencing data produced by local genomic projects and for other purposes. Sequences have been grouped by ICD10 upper categories. A web interface allows querying the database removing one or more ICD10 categories. In this way, aggregated counts of allele frequencies of the pseudo-control Spanish population can be obtained for diseases belonging to the category removed. Interestingly, in addition to pseudo-control studies, some population studies can be made, as, for example, prevalence of pharmacogenomic variants, etc. In addition, this genomic data has been used to define the first Spanish Genome Reference Panel (SGRP1.0) for imputation. This is the first local repository of variability entirely produced by a crowdsourcing effort and constitutes an example for future initiatives to characterize local variability worldwide. CSVS is also part of the GA4GH Beacon network. CSVS can be accessed at: http://csvs.babelomics.org/., Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R, PT17/0009/0006 to J.D.; PI19/00321 and CIBERER ACCI-06/07/0036 to C.A., PI14-948, PI17-1659 and CIBERER ACCI-06/07/0036 to M.A.M.P.]; Regional Government of Madrid, RAREGenomics-CM [B2017/BMD-3721 to C.A. and B2017/BMD3721 to M.A.M.P.]; all co-funded with European Regional Development Funds (ERDF) as well as EU H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE [676559]; University Chair UAM-IIS-FJD of Genomic Medicine and the Ramon Areces Foundation also supported this work. Funding for open access charge: Spanish Ministry of Economy and Competitiveness [SAF2017-88908-R]., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Phylogenetic Analysis of the 2020 West Nile Virus (WNV) Outbreak in Andalusia (Spain)

  • Casimiro-Soriguer, Carlos S.
  • Pérez-Florido, Javier
  • Fernández-Rueda, José L.
  • Pedrosa-Corral, Irene
  • Guillot-Sulay, Vicente
  • Lorusso, Nicola
  • Martínez-González, Luis Javier
  • Navarro-Marí, José María
  • Dopazo, Joaquín
  • Sanbonmatsu-Gámez, Sara
This article belongs to the Special Issue State-of-the-Art Emerging, Re-emerging and Zoonotic Viruses' Research in Spain., During recent decades West Nile Virus (WNV) outbreaks have continuously occurred in the Mediterranean area. In August 2020 a new WNV outbreak affected 71 people with meningoencephalitis in Andalusia and six more cases were detected in Extremadura (south-west of Spain), causing a total of eight deaths. The whole genomes of four viruses were obtained and phylogenetically analyzed in the context of recent outbreaks. The Andalusian viral samples belonged to lineage 1 and were relatively similar to those of previous outbreaks which occurred in the Mediterranean region. Here we present a detailed analysis of the outbreak, including an extensive phylogenetic study. As part on this effort, we implemented a local Nextstrain server, which has become a constituent piece of regional epidemiological surveillance, wherein forthcoming genomes of environmental samples or, eventually, future outbreaks, will be included., This research was funded by grants PT17/0009/0006 from the ISCIII, co-funded by the European Regional Development Fund (ERDF) as well as H2020 “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Comprehensive analysis of the isomiRome in the vegetative organs of the conifer Pinus pinaster under contrasting water availability

  • Perdiguero, Pedro
  • Rodrigues, Andreia
  • Chaves, Inês
  • Costa, Bruno
  • Alves, Ana
  • de María, Nuria
  • Vélez, M. Dolores
  • Díaz-Sala, Carmen
  • Cervera, María Teresa
  • Miguel, Célia
23 Pág. Centro de Investigación en Sanidad Animal (CISA), An increasing number of microRNAs (miRNAs) and miRNA-related sequences produced during miRNA biogenesis, comprising the isomiRome, have been recently highlighted in different species as critical mediators of environmental stress responses. Conifers have some of the largest known genomes but an extensive characterization of the isomiRome from any conifer species has been lacking. We provide here a comprehensive overview of the Pinus pinaster isomiRome expressed in roots, stem and needles under well-watered and drought conditions. From the 13,441 unique small RNA sequences identified, 2,980 were annotated as canonical miRNAs or miRNA* and the remaining were classified as isomiRNA or miRNA-like sequences. A survey of their expression patterns highlighted roots as the most responsive organ under drought, where specific sequences of which a 24-nt novel miRNA stood out, were strongly down-regulated. Given the putative roles of the miRNA-targeted transcripts validated specifically in root tissues, some of the miRNAs, conserved and novel, are shortlisted as potential regulators of drought response. These results provide a valuable resource for comparative studies between gymnosperms and angiosperms. Furthermore, it evidences high transferability of the isomiRome between pine species being a useful basis for further molecular regulation and physiological studies, and especially those focused on adaptation to drought conditions., FP7 People: Marie-Curie Actions, Grant/Award Number: PIEF-GA-2013-627761; Fundação para a Ciência e a Tecnologia, Grant/Award Numbers: IF/01168/2013, SFRH/BD/79779/2011; SFRH/BD/128827/2017; UID/Multi/04551/2013; UID/Multi/04046/2019; DL57/2016/CP1351/CT0003; Horizon 2020 Framework Programme, Grant/Award Number: 676559; Ministerio de Economía, Industria y Competitividad, Gobierno de España, Grant/Award Numbers: AGL2015-66048-C2-1-R, RTI2018-098015-B-I00; Seventh Framework Programme, Grant/Award Number: 289841, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Towards a metagenomics machine learning interpretable model for understanding the transition from adenoma to colorectal cancer

  • Casimiro-Soriguer, Carlos S.
  • Loucera, Carlos
  • Peña-Chilet, María
  • Dopazo, Joaquín
Gut microbiome is gaining interest because of its links with several diseases, including colorectal cancer (CRC), as well as the possibility of being used to obtain non-intrusive predictive disease biomarkers. Here we performed a meta-analysis of 1042 fecal metagenomic samples from seven publicly available studies. We used an interpretable machine learning approach based on functional profiles, instead of the conventional taxonomic profiles, to produce a highly accurate predictor of CRC with better precision than those of previous proposals. Moreover, this approach is also able to discriminate samples with adenoma, which makes this approach very promising for CRC prevention by detecting early stages in which intervention is easier and more effective. In addition, interpretable machine learning methods allow extracting features relevant for the classification, which reveals basic molecular mechanisms accounting for the changes undergone by the microbiome functional landscape in the transition from healthy gut to adenoma and CRC conditions. Functional profiles have demonstrated superior accuracy in predicting CRC and adenoma conditions than taxonomic profiles and additionally, in a context of explainable machine learning, provide useful hints on the molecular mechanisms operating in the microbiota behind these conditions., This work is supported by Grants PID2020-117979RB-I00 from the Spanish Ministry of Science and Innovation and PI20/01305 and IMP/0019 from the ISCIII, both co-funded with European Regional Development Funds (ERDF) as well as H2020 Programme of the European Union Grants Marie Curie Innovative Training Network "Machine Learning Frontiers in Precision Medicine" (MLFPM) (GA 813533) and “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559). The postdoctoral contract for CL PAIDI2020- DOC_00350 is funded by Junta de Andalucía and co-funded by the European Social Fund (FSE) 2014-2020., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Molecular study of drought response in the Mediterranean conifer Pinus pinaster Ait.: Differential transcriptomic profiling reveals constitutive water deficit-independent drought tolerance mechanisms

  • de María, Nuria
  • Guevara, M Ángeles
  • Perdiguero, Pedro
  • Vélez, M. Dolores
  • Cabezas Martínez, José Antonio
  • López-Hinojosa, Miriam
  • Li, Zhen
  • Diáz, Luís Manuel
  • Pizarro, Alberto
  • Mancha, José Antonio
  • Sterck, Lieven
  • Sánchez-Gómez, David
  • Miguel, Célia
  • Collada, Carmen
  • Díaz-Sala, Carmen
  • Cervera, María Teresa
20 Pág., Adaptation of long-living forest trees to respond to environmental changes is essential to secure their performance under adverse conditions. Water deficit is one of the most significant stress factors determining tree growth and survival. Maritime pine (Pinus pinaster Ait.), the main source of softwood in southwestern Europe, is subjected to recurrent drought periods which, according to climate change predictions for the years to come, will progressively increase in the Mediterranean region. The mechanisms regulating pine adaptive responses to environment are still largely unknown. The aim of this work was to go a step further in understanding the molecular mechanisms underlying maritime pine response to water stress and drought tolerance at the whole plant level. A global transcriptomic profiling of roots, stems, and needles was conducted to analyze the performance of siblings showing contrasted responses to water deficit from an ad hoc designed full-sib family. Although P. pinaster is considered a recalcitrant species for vegetative propagation in adult phase, the analysis was conducted using vegetatively propagated trees exposed to two treatments: well-watered and moderate water stress. The comparative analyses led us to identify organ-specific genes, constitutively expressed as well as differentially expressed when comparing control versus water stress conditions, in drought-sensitive and drought-tolerant genotypes. Different response strategies can point out, with tolerant individuals being pre-adapted for coping with drought by constitutively expressing stress-related genes that are detected only in latter stages on sensitive individuals subjected to drought., This work was supported by the Spanish Ministry of Economy, Industry and Competitiveness (AGL2015-66048-C2-1-R; RTI2018-098015-B-I00; IMP2018-005)]; European Union's Seventh Framework Programme 2007-2013 (FP7-289841); EU H2020 Programme (H2020-676559); Fundação para a Ciência e a Tecnologia, FCT (IF/01168/2013; UID/Multi/04551/2013); and People Programme, Marie Curie Actions (PIEF-GA-2013-627761)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

VISMapper: Ultra-fast exhaustive cartography of viral insertion sites for gene therapy

  • Juanes, José M.
  • Gallego, Asunción
  • Tárraga, Joaquín
  • Chaves, Felipe J.
  • Marin-Garcia, Pablo
  • Medina, Ignacio
  • Arnau, Vicente
  • Dopazo, Joaquín
[Background] The possibility of integrating viral vectors to become a persistent part of the host genome makes them a crucial element of clinical gene therapy. However, viral integration has associated risks, such as the unintentional activation of oncogenes that can result in cancer. Therefore, the analysis of integration sites of retroviral vectors is a crucial step in developing safer vectors for therapeutic use., [Results] Here we present VISMapper, a vector integration site analysis web server, to analyze next-generation sequencing data for retroviral vector integration sites. VISMapper can be found at: http://vismapper.babelomics.org ., [Conclusions] Because it uses novel mapping algorithms VISMapper is remarkably faster than previous available programs. It also provides a useful graphical interface to analyze the integration sites found in the genomic context., This work is supported by grants BIO2014–57291-R from the Spanish Ministry of Economy and Competitiveness (MINECO), and Plataforma de Recursos Biomoleculares y Bioinformáticos PT13/0001/0007 from the ISCIII, both co-funded with European Regional Development Funds (ERDF); H2020-INFRADEV-1-2015-1 ELIXIR-EXCELERATE (ref. 676,559)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Fair principles: Interpretations and implementation considerations

  • Jacobsen, Annika
  • De Miranda Azevedo, Ricardo
  • Juty, Nick
  • Batista, Dominique
  • Coles, Simon
  • Cornet, Ronald
  • Courtot, Mélanie
  • Crosas, Mercè
  • Dumontier, Michel
  • Evelo, Chris T. A.
  • Goble, Carole
  • Guizzardi, Giancarlo
  • Hansen, Karsten
  • Hasnain, Ali
  • Hettne, Kristina
  • Heringa, Jaap
  • Hooft, Rob W.W.
  • Imming, Melanie
  • Jeffery, Keith
  • Kaliyaperumal, Rajaram
  • Kersloot, Martijn
  • Kirkpatrick, Christine R.
  • Kuhn, Tobias
  • Labastida, Ignasi
  • Magagna, Barbara
  • McQuilton, Peter
  • Meyers, Natalie
  • Montesanti, Annalisa
  • Van Reisen, Mirjam
  • Rocca-Serra, Philippe
  • Pergl, Robert
  • Sansone, Susanna Assunta
  • Santos, Luiz Olavo Bonino da Silva
  • Schneider, Juliane
  • Strawn, George
  • Thompson, Mark
  • Waagmeester, Andra S.
  • Weigel, Tobias
  • Wilkinson, Mark D.
  • Willighagen, Egon L.
  • Wittenburg, Peter
  • Roos, Marco
  • Mons, Barend
  • Schultes, Erik
The FAIR principles have been widely cited, endorsed and adopted by a broad range of stakeholders since their publication in 2016. By intention, the 15 FAIR guiding principles do not dictate specific technological implementations, but provide guidance for improving Findability, Accessibility, Interoperability and Reusability of digital resources. This has likely contributed to the broad adoption of the FAIR principles, because individual stakeholder communities can implement their own FAIR solutions. However, it has also resulted in inconsistent interpretations that carry the risk of leading to incompatible implementations. Thus, while the FAIR principles are formulated on a high level and may be interpreted and implemented in different ways, for true interoperability we need to support convergence in implementation choices that are widely accessible and (re)-usable. We introduce the concept of FAIR implementation considerations to assist accelerated global participation and convergence towards accessible, robust, widespread and consistent FAIR implementations. Any self-identified stakeholder community may either choose to reuse solutions from existing implementations, or when they spot a gap, accept the challenge to create the needed solution, which, ideally, can be used again by other communities in the future. Here, we provide interpretations and implementation considerations (choices and challenges) for each FAIR principle., The work of A. Jacobsen, C. Evelo, M. Thompson, R. Cornet, R. Kaliyaperuma and M. Roos is supported by funding from the European Union’s Horizon 2020 research and innovation program under the EJP RD COFUND-EJP N° 825575. The work of A. Jacobsen, C. Evelo, C. Goble, M. Thompson, N. Juty, R. Hooft, M. Roos, S-A. Sansone, P. McQuilton, P. Rocca-Serra and D. Batista is supported by funding from ELIXIR EXCELERATE, H2020 grant agreement number 676559. R. Hooft was further funded by NL NWO NRGWI. obrug.2018.009. N. Juty and C. Goble were funded by CORBEL (H2020 grant agreement 654248). N. Juty, C. Goble, S-A. Sansone, P. McQuilton, P. Rocca-Serra and D. Batista were funded by FAIRplus (IMI grant agreement 802750). N. Juty, C. Goble, M. Thompson, M. Roos, S-A. Sansone, P. McQuilton, P. Rocca-Serra and D. Batista were funded by EOSClife H2020-EU (grant agreement number 824087). C. Goble was funded by DMMCore (BBSRC BB/M013189/). M. Thompson, M. Roos received funding from NWO (VWData 400.17.605). S-A. Sansone, P. McQuilton, P. Rocca-Serra and D. Batista have been funded by grants awarded to S-A. Sansone from the UK BBSRC and Research Councils (BB/L024101/1; BB/L005069/1), EU (H2020-EU 634107; H2020-EU 654241, IMI (IMPRiND 116060), NIH Data Common Fund, and from the Wellcome Trust (ISA-InterMine 212930/Z/18/Z; FAIRsharing 208381/A/17/Z). The work of A. Waagmeester has been funded by grant award number GM089820 from the National Institutes of Health. M. Kersloot was funded by the European Regional Development Fund (KVW-00163). The work of N. Meyers was funded by the National Science Foundation (OAC 1839030). The work of M.D. Wilkinson is funded by Isaac Peral/Marie Curie cofund with the Universidad Politécnica de Madrid and the Ministerio de Economía y Competitividad grant number TIN2014-55993-RM. The work of B. Magagna, E. Schultes, L. da Silva Santos and K. Jeffery is funded by the H2020-EU 824068. The work of B. Magagna, E. Schultes and L. da Silva Santos is funded by the GO FAIR ISCO grant of the Dutch Ministry of Science and Culture. The work of G. Guizzardi is supported by the OCEAN Project (FUB). M. Courtot received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 802750. R. Cornet was further funded by FAIR4Health (H2020-EU grant agreement number 824666). K. Jeffery received funding from EPOS-IP H2020-EU agreement 676564 and ENVRIplus H2020-EU agreement 654182., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Building Expertise on FAIR Through Evolving Bring Your Own Data (BYOD) Workshops: Describing the Data, Software, and Management-focused Approaches and Their Evolution

  • Bernabé, César Henrique
  • Thielemans, Lieze
  • Kaliyaperumal, Rajaram
  • Carta, Claudio
  • Zhang, Shuxin
  • van Gelder, Celia W.G.
  • Benis, Nirupama
  • Santos, Luiz Olavo Bonino da Silva
  • Cornet, Ronald
  • Vieira, Bruna Dos Santos
  • Lalout, Nawel
  • Henriques, Ines
  • Cámara, Alberto
  • Burger, Kees
  • Kersloot, Martijn
  • Ehrhart, Friederike
  • van Enckevort, Esther
  • Evelo, Chris T. A.
  • Gray, Alasdair J.G.
  • Hanauer, Marc
  • Hettne, Kristina
  • De Ligt, Joep
  • Pereira, Arnaldo
  • Queralt-Rosinach, Núria
  • Schultes, Erik
  • Taruscio, Domenica
  • Waagmeester, Andra S.
  • Wilkinson, Mark D.
  • Willighagen, Egon L.
  • Jansen, Mascha
  • Mons, Barend
  • Roos, Marco
  • Jacobsen, Annika
28 Pág., Since 2014, “Bring Your Own Data” workshops (BYODs) have been organised to inform people about the process and benefits of making resources Findable, Accessible, Interoperable, and Reusable (FAIR, and the FAIRification process). The BYOD workshops’ content and format differ depending on their goal, context, and the background and needs of participants. Data-focused BYODs educate domain experts on how to make their data FAIR to find new answers to research questions. Management-focused BYODs promote the benefits of making data FAIR and instruct project managers and policy-makers on the characteristics of FAIRification projects. Software-focused BYODs gather software developers and experts on FAIR to implement or improve software resources that are used to support FAIRification. Overall, these BYODs intend to foster collaboration between different types of stakeholders involved in data management, curation, and reuse (e.g. domain experts, trainers, developers, data owners, data analysts, FAIR experts). The BYODs also serve as an opportunity to learn what kind of support for FAIRification is needed from different communities and to develop teaching materials based on practical examples and experience. In this paper, we detail the three different structures of the BYODs and describe examples of early BYODs related to plant breeding data, and rare disease registries and biobanks, which have shaped the structure of the workshops. We discuss the latest insights into making BYODs more productive by leveraging our almost ten years of training experience in these workshops, including successes and encountered challenges. Finally, we examine how the participants’ feedback has motivated the research on FAIR, including the development of workflows and software., We would like to express our gratitude to the following individuals, institutions, and funding sources for their contributions to the realisation of the Bring Your Own Data (BYOD) workshops: the Bring Your Own Data Workshop To Link Rare Disease Registries (RD-BYOD) initiative received support from the RD-Connect project (funded from the European Community’s Seventh Framework Program under grant agreement n° 305444 “RD-CONNECT”), ELIXIR and ELIXIR-EXCELERATE (Grant number EU H2020 #676559), the Istituto Superiore di Sanità (ISS), the Leiden University Medical Center (LUMC), the University Medical Center Groningen, and the Dutch Techcentre for Life Sciences (DTL) between 2014 and 2018. From 2019 to 2023, the RD-BYOD has been funded by the European Joint Programme Rare Diseases (EJP RD) and its partners (European Union Horizon 2020 Research and Innovation Programme under Grant Agreement n° 825575), and we are grateful for their continued support. We would also like to acknowledge the Trusted World of Corona (TWOC) project funded by Health-Holland. Finally, we would also like to extend our appreciation to all the attendees and trainers who actively participated in the various BYODs, particularly representatives from patient organisations. Their engagement, insights, and expertise have significantly enriched our work and shaped its outcomes., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

A Genomic Surveillance Circuit for Emerging Viral Pathogens

  • Casimiro-Soriguer, Carlos S.
  • Lara, María
  • Aguado, Andrea
  • Loucera, Carlos
  • Ortuño, Francisco M.
  • Lorusso, Nicola
  • Navarro-Marí, José María
  • Sanbonmatsu-Gámez, Sara
  • Camacho‐Martínez, Pedro
  • Merino Díaz, Laura
  • Salazar, Adolfo de
  • Fuentes, Ana
  • Lepe, José A.
  • García, Federico
  • Dopazo, Joaquín
  • Pérez-Florido, Javier
Genomic surveillance has been crucial in monitoring the evolution and spread of SARS-CoV-2. In Andalusia (Spain), a coordinated genomic surveillance circuit was established to systematically sequence and analyze viral genomes across the region. This initiative integrates sample collection from 27 hospitals, with sequencing performed at three reference laboratories and a centralized bioinformatics platform for data analysis and reporting. Between 2021 and 2025, over 42,500 SARS-CoV-2 genomes were sequenced, enabling the identification of major variants and their evolutionary dynamics. The circuit tracked the transition from Alpha and Delta to successive Omicron waves, including both recombinant and non-recombinant clades. The integration of genomic and epidemiological data facilitated rapid variant detection, outbreak investigation, and public health decision-making. This surveillance framework demonstrates the feasibility of large-scale sequencing within a decentralized healthcare system and has expanded to monitor other pathogens, reinforcing its value for epidemic preparedness. Continued investment in genomic surveillance is critical for tracking viral evolution, guiding interventions, and mitigating future public health threats., This study has been funded by the European Union’s EU4Health programme (EU4HEALTH - 101113109), and the HERA incubator plan (ECDC/HERA/2021/024 ECD.12241). JD has been supported by grant PT17/0009/0006 from the ISCIII, co-funded by the European Regional Development Fund (ERDF), as well as the European Commision’s H2020 ELIXIR-EXCELERATE (Grant Agreeement No. 676559) and by the Consejería de Salud y Familias-Junta de Andalucía (COVID-0012-2020)., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A Genomic Surveillance Circuit for Emerging Viral Pathogens

  • Casimiro-Soriguer, Carlos S.
  • Lara, Maria
  • Aguado, Andrea
  • Loucera, Carlos
  • Ortuño, Francisco M.
  • Lorusso, Nicola
  • Navarro-Marí, Jose M.
  • Sanbonmatsu-Gámez, Sara
  • Camacho-Martinez, Pedro
  • Merino-Diaz, Laura
  • de Salazar, Adolfo
  • Fuentes, Ana
  • The Andalusian Covid-Sequencing Initiative
  • Lepe, Jose A.
  • García, Federico
  • Dopazo, Joaquín
  • Perez-Florido, Javier
The SARS-CoV-2 whole-genome sequences described in this study are available in the European Nucleotide Archive (ENA) under the identifier PRJEB44396 and in GISAID., Genomic surveillance has been crucial in monitoring the evolution and spread of SARS-CoV-2. In Andalusia (Spain), a coordinated genomic surveillance circuit was established to systematically sequence and analyze viral genomes across the region. This initiative organizes sample collection through 27 hospitals, which act as regional hubs within their respective health districts. Sequencing is performed at three reference laboratories, with downstream data analysis and reporting centralized at a bioinformatics platform. From 2021 to 2025, over 42,500 SARS-CoV-2 genomes were sequenced, enabling the identification of major variants and their evolutionary dynamics. The circuit tracked the transition from Alpha and Delta to successive Omicron waves, including both recombinant and non-recombinant clades. The integration of genomic and epidemiological data facilitated rapid variant detection, outbreak investigation, and public health decision making. This surveillance framework at a regional granularity demonstrates the feasibility of large-scale sequencing within a decentralized healthcare system and has expanded to monitor other pathogens, reinforcing its value for epidemic preparedness. Continued investment in genomic surveillance is critical for tracking viral evolution, guiding interventions, and mitigating future public health threats., This study has been funded by the European Union’s EU4Health programme (EU4HEALTH-101113109), and the HERA incubator plan (ECDC/HERA/2021/024 ECD.12241). J.D. has been supported by grant PT17/0009/0006 from the ISCIII, co-funded by the European Regional Development Fund (ERDF), as well as the European Commission’s H2020 ELIXIR-EXCELERATE (Grant Agreement No. 676559) and by the Consejería de Salud y Familias-Junta de Andalucía (COVID-0012-2020)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

First autochthonous transmission of West Nile virus (WNV) lineage 2 to humans in Spain

  • Lara, Maria
  • Casimiro-Soriguer, Carlos S.
  • Pedrosa-Corral, Irene
  • Gómez-Camarasa, Cristina
  • Lorusso, Nicola
  • Navarro-Marí, José M.
  • Dopazo, Joaquin
  • Perez-Florido, Javier
  • Sanbonmatsu-Gámez, Sara
ata is available in the European Nucleotide Archive (ENA) database under the project identifier PRJEB43037, sample accession ERS22985467, West Nile Virus (WNV) lineage 2, primarily endemic to parts of Africa and Europe, has recently emerged as a public health concern in new geographic regions. In 2024, the first autochthonous human case of neuroinvasive disease caused by WNV lineage 2 was identified in Andalusia, Southern Spain. Molecular testing and whole-genome sequencing confirmed WNV lineage 2 as the causative agent. Phylogenetic analysis revealed a close relationship with strains circulating in Central Europe, distinct from previous WNV lineage 2 detections in Spain. Concurrently, WNV lineage 2 RNA was detected in an imperial eagle near the case location, suggesting local viral circulation. This case marks a significant shift in WNV epidemiology in Spain, where lineage 1 has historically been dominant. The findings underscore the expanding range of WNV lineage 2 and the necessity for enhanced vector surveillance, genomic monitoring, and strengthened One Health strategies to mitigate future outbreaks and protect public health., This research was funded by grants PT17/0009/0006 from the ISCIII, co-funded by the European Regional Development Fund (ERDF) as well as H2020 “ELIXIR-EXCELERATE fast-track ELIXIR implementation and drive early user exploitation across the life sciences” (GA 676559). We thank the Laboratorio Central de Veterinaria, Algete-Madrid for sharing with us the partial sequence of the WNV isolated from an imperial eagle in the same region and date than the virus studied here., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Patient dossier: healthcare queries over distributed resources

  • Vazquez, Miguel
  • Valencia, Alfonso|||0000-0002-8937-6789
As with many other aspects of the modern world, in healthcare, the explosion of data and resources opens new opportunities for the development of added-value services. Still, a number of specific conditions on this domain greatly hinders these developments, including ethical and legal issues, fragmentation of the relevant data in different locations, and a level of (meta)data complexity that requires great expertise across technical, clinical, and biological domains. We propose the Patient Dossier paradigm as a way to organize new innovative healthcare services that sorts the current limitations. The Patient Dossier conceptual framework identifies the different issues and suggests how they can be tackled in a safe, efficient, and responsible way while opening options for independent development for different players in the healthcare sector. An initial implementation of the Patient Dossier concepts in the Rbbt framework is available as open-source at https://github.com/mikisvaz and https://github.com/Rbbt-Workflows., This work has received funding from the Elixir-Excelerate project, from the European Union's Horizon 2020 Research and Innovation Programme, under grant agreement N. 676559, and from Plataforma de Recursos Biomoleculares y Bioinformáticos PT13/0001/0030. Additional support came from the Lenovo - BSC Master Collaboration Agreement (2015) and from the IBM-BSC Deep Learning Centre (2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

The Multiple Roles of Waters in Protein Solvation

  • Hospital, Adam
  • Candotti, Michela
  • Gelpí, Josep Lluís
  • Orozco, Modesto
Extensive molecular dynamics (MD) simulations have been used to characterize the multiple roles of water in solvating different types of proteins under different environmental conditions. We analyzed a small set of proteins, representative of the most prevalent meta-folds under native conditions, in the presence of crowding agents, and at high temperature with or without high concentration of urea. We considered also a protein in the unfolded state as characterized by NMR and atomistic MD simulations. Our results outline the main characteristics of the hydration environment of proteins and illustrate the dramatic plasticity of water, and its chameleonic ability to stabilize proteins under a variety of conditions., The authors thank INB (Instituto Nacional de Bioinformática) for support in this project. Additional funding to this project comes from H2020 (BioExcel GA 675728, Elixir-Excelerate GA 676559) and the Spanish MINECO (BIO2015/64802-R) funding agencies. IRB Barcelona is recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain, GA SEV-2015-050). MO is an ICREA Academia researcher., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

The effects of death and post-mortem cold ischemia on human tissue transcriptomes

  • Ferreira, Pedro G.
  • Muñoz Aguirre, Manuel
  • Reverter Comes, Ferran|||0000-0002-9489-3350
Post-mortem tissues samples are a key resource for investigating patterns of gene expression. However, the processes triggered by death and the post-mortem interval (PMI) can significantly alter physiologically normal RNA levels. We investigate the impact of PMI on gene expression using data from multiple tissues of post-mortem donors obtained from the GTEx project. We find that many genes change expression over relatively short PMIs in a tissue-specific manner, but this potentially confounding effect in a biological analysis can be minimized by taking into account appropriate covariates. By comparing ante- and post-mortem blood samples, we identify the cascade of transcriptional events triggered by death of the organism. These events do not appear to simply reflect stochastic variation resulting from mRNA degradation, but active and ongoing regulation of transcription. Finally, we develop a model to predict the time since death from the analysis of the transcriptome of a few readily accessible tissues., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

BioExcel Building Blocks, a software library for interoperable biomolecular simulation workflows

  • Andrio, Pau
  • Hospital, Adam
  • Conejero Bañón, Javier
  • Jordá, Luis
  • del Pino, Marc
  • Codo, Laia
  • Soiland Reyes, Stian
  • Goble, Carole
  • Lezzi, Daniele|||0000-0001-5081-7244
  • Badia Sala, Rosa Maria|||0000-0003-2941-5499
  • Orozco López, Modesto
  • Gelpi Buchaca, Josep Lluís
In the recent years, the improvement of software and hardware performance has made biomolecular simulations a mature tool for the study of biological processes. Simulation length and the size and complexity of the analyzed systems make simulations both complementary and compatible with other bioinformatics disciplines. However, the characteristics of the software packages used for simulation have prevented the adoption of the technologies accepted in other bioinformatics fields like automated deployment systems, workflow orchestration, or the use of software containers. We present here a comprehensive exercise to bring biomolecular simulations to the “bioinformatics way of working”. The exercise has led to the development of the BioExcel Building Blocks (BioBB) library. BioBB’s are built as Python wrappers to provide an interoperable architecture. BioBB’s have been integrated in a chain of usual software management tools to generate data ontologies, documentation, installation packages, software containers and ways of integration with workflow managers, that make them usable in most computational environments., We thank The Barcelona Supercomputing Center for providing all the HPC resources to launch the test executions presented in this manuscript. Te project was supported by the following grants: BioExcel Center of Excellence (Horizon 2020 Framework Programme. Grants 675728, and 823830). Elixir-Excelerate (Horizon 2020 Framework Programme. Grant 676559). Spanish National Institute for Bioinformatics (Institute of Health Carlos III. Grants PT13/0001/0019, PT13/0001/0028, PT17/0009/0001). Spanish Government, Severo Ochoa Grant SEV2015-0493, TIN2015-65316-P, Generalitat de Catalunya. 2014-SGR-1051, 2017-SGR-1110., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Ten steps to get started in Genome Assembly and Annotation

  • Dominguez del Angel, Victoria
  • Hjerde, Erik
  • Sterck, Lieven
  • Capella-Gutierrez, Salvador
  • Notredame, Cederic
  • Vinnere Pettersson, Olga
  • Amselem, Joelle
  • Bouri, Laurent
  • Bocs, Stephanie
  • Klopp, Christophe
  • Gibrat, Jean-Francois
  • Vlasova, Anna
  • Leskosek, Brane L.
  • Soler, Lucile
  • Binzer-Panchal, Mahesh
  • Lantz, Henrik
As a part of the ELIXIR-EXCELERATE efforts in capacity building, we present here 10 steps to facilitate researchers getting started in genome assembly and genome annotation. The guidelines given are broadly applicable, intended to be stable over time, and cover all aspects from start to finish of a general assembly and annotation project. Intrinsic properties of genomes are discussed, as is the importance of using high quality DNA. Different sequencing technologies and generally applicable workflows for genome assembly are also detailed. We cover structural and functional annotation and encourage readers to also annotate transposable elements, something that is often omitted from annotation workflows. The importance of data management is stressed, and we give advice on where to submit data and how to make your results Findable, Accessible, Interoperable, and Reusable (FAIR)., ELIXIR-EXCELERATE is funded by the European Commission within the Research Infrastructures Programme of Horizon 2020 [676559]., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

The Functional Impact of Alternative Splicing in Cancer

  • Climente-Gonzalez, Héctor
  • Porta-Pardo, Eduard
  • Godzik, Adam
  • Eyras, Eduardo
Alternative splicing changes are frequently observed in cancer and are starting to be recognized as important signatures for tumor progression and therapy. However, their functional impact and relevance to tumorigenesis remain mostly unknown. We carried out a systematic analysis to characterize the potential functional consequences of alternative splicing changes in thousands of tumor samples. This analysis revealed that a subset of alternative splicing changes affect protein domain families that are frequently mutated in tumors and potentially disrupt protein-protein interactions in cancer-related pathways. Moreover, there was a negative correlation between the number of these alternative splicing changes in a sample and the number of somatic mutations in drivers. We propose that a subset of the alternative splicing changes observed in tumors may represent independent oncogenic processes that could be relevant to explain the functional transformations in cancer, and some of them could potentially be considered alternative splicing drivers (AS drivers)., H.C.-G. and E.E. were supported by the MINECO and FEDER (BIO2014-52566-R), Consolider RNAREG (CSD2009-00080), AGAUR (SGR2014-1121), the European ITN Network RNP-Net (ID: 289007), and the Sandra Ibarra Foundation for Cancer (FSI2013). E.P.-P. and A.G. were supported by the SBP CC grant (P30 CA030199). All authors thank The Cancer Genome Atlas project for making their data publicly available. The Computational RNA Biology Group is part of the Research Programme on Biomedical Informatics (GRIB), which is a member of ELIXIR-Excelerate of the European Union Horizon 2020 Programme 2014-2020 (No. 676559) and of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023 of the PE I+D+I 2013-2016, funded by ISCIII and FEDER., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

MetaShot: an accurate workflow for taxon classification of host-associated microbiome from shotgun metagenomic data

  • Fosso, Bruno
  • Santamaria, Monica
  • D'Antonio, M.
  • Lovero, D.
  • Corrado, G.
  • Vizza, E.
  • Passaro, N.
  • Garbuglia, A.R.
  • Capobianchi, M.R.
  • Crescenzi, M.
  • Valiente Feruglio, Gabriel Alejandro|||0000-0001-9194-2703
  • Pesole, Graziano
Shotgun metagenomics by high-throughput sequencing may allow deep and accurate characterization of host-associated total microbiomes, including bacteria, viruses, protists and fungi. However, the analysis of such sequencing data is still extremely challenging in terms of both overall accuracy and computational efficiency, and current methodologies show substantial variability in misclassification rate and resolution at lower taxonomic ranks or are limited to specific life domains (e.g. only bacteria). We present here MetaShot, a workflow for assessing the total microbiome composition from host-associated shotgun sequence data, and show its overall optimal accuracy performance by analyzing both simulated and real datasets., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

A framework to assess the quality and impact of bioinformatics training across ELIXIR

  • Gurwitz, Kim T.
  • Singh Gaur, Prakash
  • Bellis, Louisa J.
  • Larcombe, Lee
  • Alloza, Eva
  • Laszlo Balint, Balint
  • Botzki, Alexander
  • Dimec, Jure
  • Dominguez del Angel, Victoria
  • Fernandes, Pedro L.
  • Korpelainen, Eija
  • Krause, Roland
  • Kuzak, Mateusz
  • Le Pera, Loredana
  • Leskošek, Brane
  • Lindvall, Jessica M.
  • Marek, Diana
  • Martinez, Paula A.
  • Muyldermans, Tuur
  • Nygård, Ståle
  • Palagi, Patricia M.
  • Peterson, Hedi
  • Psomopoulos, Fotis
  • Spiwok, Vojtech
  • Gelder, Celia W. G. van
  • Via, Allegra
  • Vidak, Marko
  • Wibberg, Daniel
  • Morgan, Sarah L.
  • Rustici, Gabriella
ELIXIR is a pan-European intergovernmental organisation for life science that aims to coordinate bioinformatics resources in a single infrastructure across Europe; bioinformatics training is central to its strategy, which aims to develop a training community that spans all ELIXIR member states. In an evidence-based approach for strengthening bioinformatics training programmes across Europe, the ELIXIR Training Platform, led by the ELIXIR EXCELERATE Quality and Impact Assessment Subtask in collaboration with the ELIXIR Training Coordinators Group, has implemented an assessment strategy to measure quality and impact of its entire training portfolio. Here, we present ELIXIR’s framework for assessing training quality and impact, which includes the following: specifying assessment aims, determining what data to collect in order to address these aims, and our strategy for centralised data collection to allow for ELIXIR-wide analyses. In addition, we present an overview of the ELIXIR training data collected over the past 4 years. We highlight the importance of a coordinated and consistent data collection approach and the relevance of defining specific metrics and answer scales for consortium-wide analyses as well as for comparison of data across iterations of the same course., ELIXIR-EXCELERATE is funded by the European Commission within the Research Infrastructures programme of Horizon 2020, grant agreement number 676559 (https://ec.europa.eu/programmes/horizon2020/en/area/researchinfrastructures). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

BIGNASim: a NoSQL database structure and analysis portal for nucleic acids simulation data

  • Hospital, Adam
  • Andrio, Pau
  • Cugnasco, Cesare
  • Codo, Laia
  • Becerra Fontal, Yolanda|||0000-0003-2357-7796
  • Dans, Pablo D.
  • Battistini, Federica
  • Torres Viñals, Jordi|||0000-0003-1963-7418
  • Goñi, Ramon
  • Orozco, Modesto
  • Gelpí, Josep Lluís
Molecular dynamics simulation (MD) is, just behind genomics, the bioinformatics tool that generates the largest amounts of data, and that is using the largest amount of CPU time in supercomputing centres. MD trajectories are obtained after months of calculations, analysed in situ, and in practice forgotten. Several projects to generate stable trajectory databases have been developed for proteins, but no equivalence exists in the nucleic acids world. We present here a novel database system to store MD trajectories and analyses of nucleic acids. The initial data set available consists mainly of the benchmark of the new molecular dynamics force-field, parmBSC1. It contains 156 simulations, with over 120 mu s of total simulation time. A deposition protocol is available to accept the submission of new trajectory data. The database is based on the combination of two NoSQL engines, Cassandra for storing trajectories and MongoDB to store analysis results and simulation metadata. The analyses available include backbone geometries, helical analysis, NMR observables and a variety of mechanical analyses. Individual trajectories and combined meta-trajectories can be downloaded from the portal. The system is accessible through http://mmb.irbbarcelona.org/BIGNASim/. Supplementary Material is also available on-line at http://mmb.irbbarcelona.org/BIGNASim/SuppMaterial/., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

The quest for orthologs benchmark service and consensus calls in 2020

  • Altenhoff, Adrian M
  • Garrayo Ventas, Javier
  • Consentino, Salvatore
  • Emms, David
  • Glover, Natasha M
  • Hernández Plaza, Ana
  • Nevers, Yannis
  • Szklarczyk, Damian
  • Fernández González, Jose María|||0000-0002-4806-5140
  • Codó, Laia
  • Gelpi, Josep|||0000-0002-0566-7723
  • Huertas Cepas, Jaime
  • Iwasaki, Wataru
  • Kelly, Steven
  • Lecompte, Odile
  • Muffato, Matthieu
  • Martín, María Jesús
  • Capella Gutiérrez, Salvador|||0000-0002-0309-604X
  • Thomas, Paul D.
  • Sonnhammer, Erik
  • Dessimoz, Christophe
  • the Quest for Orthologs Consortium
The identification of orthologs—genes in different species which descended from the same gene in their last common ancestor—is a prerequisite for many analyses in comparative genomics and molecular evolution. Numerous algorithms and resources have been conceived to address this problem, but benchmarking and interpreting them is fraught with difficulties (need to compare them on a common input dataset, absence of ground truth, computational cost of calling orthologs). To address this, the Quest for Orthologs consortium maintains a reference set of proteomes and provides a web server for continuous orthology benchmarking (http://orthology.benchmarkservice.org). Furthermore, consensus ortholog calls derived from public benchmark submissions are provided on the Alliance of Genome Resources website, the joint portal of NIH-funded model organism databases., Service and Infrastructure grant from the Swiss Institute of Bioinformatics [to C.D.]; NSF [1917302 to P.D.T.]; NIH NHGRI [HG002273, HG010859 to P.D.T.]; INB [PT17/0009/0001 - ISCIII-SGEFI/ERDF to J.G.V., V.S., J.M.F., L.C., J.L.G. and S.C.G.]; H2020 ELIXIR-EXCELERATE [676559 to J.G.V., V.S., J.M.F., L.C., J.L.G. and S.C.G]; ELIXIR, the research infrastructure for life-science data [to J.G.V., V.S., J.M.F., L.C., J.L.G. and S.C.G]; Ministerio de Ciencia, Innovación y Universidades [PGC2018-098073-A-I00 MCIU/AEI/FEDER, UE to J.H.C.]; European Union's Horizon 2020 Research and Innovation Programme [686070 to J.H.C. and D.S, and 637765 to D.M.E. and S.K.]; Consejería de Educación, Juventud y Deporte de la Comunidad de Madrid and Fondo Social Europeo [PEJ-2017-AI/TIC-7514 to A.H.P.]; IdEX Unistra in the framework of the Investments for the future program of the French government [to O.L.]; National Institutes of Health (NIH) [U24HG007822 to M.J.M.]; European Molecular Biology Laboratory (EMBL) [core funds to M.J.M and M.M.]; Wellcome Trust [WT108749/Z/15/Z to M.M.]; S.K. is a royal Society University Research Fellow; Swiss National Science Foundation [183723 to C.D.]. Funding for open access charge: Swiss National Science Foundation., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

PMut: a web-based tool for the annotation of pathological variants on proteins, 2017 update

  • López-Ferrando, Víctor
  • Gazzo, Andrea
  • de la Cruz, Xavier
  • Orozco, Modesto
  • Gelpí, Josep Lluís
We present here a full update of the PMut predictor, active since 2005 and with a large acceptance in the field of predicting Mendelian pathological mutations. PMut internal engine has been renewed, and converted into a fully featured standalone training and prediction engine that not only powers PMut web portal, but that can generate custom predictors with alternative training sets or validation schemas. PMut Web portal allows the user to perform pathology predictions, to access a complete repository of pre-calculated predictions, and to generate and validate new predictors. The default predictor performs with good quality scores (MCC values of 0.61 on 10-fold cross validation, and 0.42 on a blind test with SwissVar 2016 mutations). The PMut portal is freely accessible at http://mmb.irbbarcelona.org/PMut. A complete help and tutorial is available at http://mmb.irbbarcelona.org/PMut/help., Spanish Ministry of Science [BIO2015-64802-R-32868, SEV-2015-0493, TIN2012-34557, TEC2015-67774-C2-2-R, SAF2016-80255-R]; Catalan Government [2014-SGR-134, 2014-SGR-1051]; Instituto de Salud Carlos III-Instituto Nacional de Bioinformática [INB; PT13/0001/0019, PT13/0001/0028]; European Union, H2020 programme [Elixir-Excelerate: 676559; BioExcel: 674728 and MuG: 676566]; La Caixa Foundation fellowship [to V.L.F.]. Funding for open access charge: European Union and Spanish Ministry of Science., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

A catalogue of 863 Rett-syndrome-causing MECP2 mutations and lessons learned from data integration

  • Ehrhart, Friederike
  • Jacobsen, Annika
  • Rigau, Maria|||0000-0002-6501-7212
  • Bosio, Mattia
  • Kaliyaperumal, Rajaram
  • Laros, Jeroen F. J.
  • Willighagen, Egon L.
  • Valencia, Alfonso|||0000-0002-8937-6789
  • Roos, Marco
  • Capella Gutiérrez, Salvador|||0000-0002-0309-604X
  • Curfs, Leopold M. G.
  • Evelo, Chris T.
Rett syndrome (RTT) is a rare neurological disorder mostly caused by a genetic variation in MECP2. Making new MECP2 variants and the related phenotypes available provides data for better understanding of disease mechanisms and faster identification of variants for diagnosis. This is, however, currently hampered by the lack of interoperability between genotype-phenotype databases. Here, we demonstrate on the example of MECP2 in RTT that by making the genotype-phenotype data more Findable, Accessible, Interoperable, and Reusable (FAIR), we can facilitate prioritization and analysis of variants. In total, 10,968 MECP2 variants were successfully integrated. Among these variants 863 unique confirmed RTT causing and 209 unique confirmed benign variants were found. This dataset was used for comparison of pathogenicity predicting tools, protein consequences, and identification of ambiguous variants. Prediction tools generally recognised the RTT causing and benign variants, however, there was a broad range of overlap Nineteen variants were identified that were annotated as both disease-causing and benign, suggesting that there are additional factors in these cases contributing to disease development., The authors would like to thank the Mutalyzer team for support and feedback, Henk van Kranen for support in liftover of ancient genetic variant descriptions, and Eric Smeets for collection of the Maastricht Rett dataset.This work was funded by ELIXIR (funded by the European Commission within the Research Infrastructures programme of Horizon 2020), the research infrastructure for life-science data (MolData2). FE and LC were also funded by The Dutch Rett Syndrome Foundation (Stichting Terre). CE, AJ, RK, AV, SCG, MB, MRi and MR also received funding from EXCELERATE (H2020, Grant No. 676559). AJ, RK, MR, MB, and SCG also received funding from RD-Connect, European Union Seventh Framework Programme (FP7/2007–2013, Grant No. 305444). FE, CE, AJ, RK, MR, MB, and SCG received funding from the European Union’s Horizon 2020 Research and Innovation Program under grant agreement EJP RD N°825575. RK was also funded by NWO in project VWData (grant no. 400.17.605) and BBMRI-NL (NWO, National Roadmap for Large-Scale Research Facilities, grant no. 184.033.111). AV and SCG also received funding from INB Grant (Grant No. PT17/0009/0001 - ISCIII-SGEFI / ERDF)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Unbiased taxonomic annotation of metagenomic samples

  • Fosso, Bruno
  • Pesole, Graziano
  • Rosselló Llompart, Francesc A.
  • Valiente Feruglio, Gabriel Alejandro|||0000-0001-9194-2703
The classification of reads from a metagenomic sample using a reference taxonomy is usually based on first mapping the reads to the reference sequences and then classifying each read at a node under the lowest common ancestor of the candidate sequences in the reference taxonomy with the least classification error. However, this taxonomic annotation can be biased by an imbalanced taxonomy and also by the presence of multiple nodes in the taxonomy with the least classification error for a given read. In this article, we show that the Rand index is a better indicator of classification error than the often used area under thereceiver operating characteristic (ROC) curve andF-measure for both balanced and imbalanced reference taxonomies, and we also address the second source of bias by reducing the taxonomic annotation problem for a whole metagenomic sample to a set cover problem, for which a logarithmic approximation can be obtained in linear time and an exact solution can be obtained by integer linear programming. Experimental results with a proof-of-concept implementation of the set cover approach to taxonomic annotation in a next release of the TANGO software show that the set cover approach further reduces ambiguity in the taxonomic annotation obtained with TANGO without distorting the relative abundance profile of the metagenomic sample., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

BIGNASim: a NoSQL database structure and analysis portal for nucleic acids simulation data.

  • Hospital, Adam
  • Andrio, Pau
  • Cugnasco, Cesare
  • Codó, Laia
  • Becerra Fontal, Yolanda|||0000-0003-2357-7796
  • Dans, Pablo D.
  • Battistini, Federica
  • Torres Viñals, Jordi|||0000-0003-1963-7418
  • Goni, Ramón
  • Orozco, Modesto
  • Gelpí, Josep Lluís
Molecular dynamics simulation (MD) is, just behind genomics, the bioinformatics tool that generates the largest amounts of data, and that is using the largest amount of CPU time in supercomputing centres. MD trajectories are obtained after months of calculations, analysed in situ, and in practice forgotten. Several projects to generate stable trajectory databases have been developed for proteins, but no equivalence exists in the nucleic acids world. We present here a novel database system to store MD trajectories and analyses of nucleic acids. The initial data set available consists mainly of the benchmark of the new molecular dynamics force-field, parmBSC1. It contains 156 simulations, with over 120 of total simulation time. A deposition protocol is available to accept the submission of new trajectory data. The database is based on the combination of two NoSQL engines, Cassandra for storing trajectories and MongoDB to store analysis results and simulation metadata. The analyses available include backbone geometries, helical analysis, NMR observables and a variety of mechanical analyses. Individual trajectories and combined meta-trajectories can be downloaded from the portal. The system is accessible through http: //mmb.irbbarcelona.org/BIGNASim/. Supplementary Material is also available on-line at http://mmb. irbbarcelona.org/BIGNASim/SuppMaterial/., Spanish Ministry of Science [BIO2012-32868, SEV-2011-00067, TIN2012-34557]; Catalan Government [2014-SGR-134, 2014-SGR-1051]; Institut Català de Recerca I Estudis Avanc¸ats, ICREA Academia [to M.O.], Instituto de Salud Carlos III-Instituto Nacional de Bioinformática [PT13/0001/0019, PT13/0001/0028]; European Research Council [ERC SimDNA]; European Union, H2020 programme [Elixir-Excellerate: 676559; BioExcel: 674728, MuG: 676566]; PEDECIBA and SNI (ANII, Uruguay) [to P.D.D.]. Funding for open access charge: European Union [MuG: 676566]., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo preliminar (WorkingPaper)

Lessons Learned: Recommendations for Establishing Critical Periodic Scientific Benchmarking

  • Capella-Gutierrez, Salvador
  • de la Iglesia, Diana
  • Haas, Juergen
  • Lourenco, Analia
  • Fernandez, José M.
  • Repchevsky, Dmitry
  • Dessimoz, Christophe
  • Schwede, Torsten
  • Notredame, Cedric
  • Gelpí, Josep Lluís
  • Valencia, Alfonso|||0000-0002-8937-6789
The dependence of life scientists on software has steadily grown in recent years. For many tasks, researchers have to decide which of the available bioinformatics software are more suitable for their specific needs. Additionally researchers should be able to objectively select the software that provides the highest accuracy, the best efficiency and the highest level of reproducibility when integrated in their research projects. Critical benchmarking of bioinformatics methods, tools and web services is therefore an essential community service, as well as a critical component of reproducibility efforts. Unbiased and objective evaluations are challenging to set up and can only be effective when built and implemented around community driven efforts, as demonstrated by the many ongoing community challenges in bioinformatics that followed the success of CASP. Community challenges bring the combined benefits of intense collaboration, transparency and standard harmonization. Only open systems for the continuous evaluation of methods offer a perfect complement to community challenges, offering to larger communities of users that could extend far beyond the community of developers, a window to the developments status that they can use for their specific projects. We understand by continuous evaluation systems as those services which are always available and periodically update their data and/or metrics according to a predefined schedule keeping in mind that the performance has to be always seen in terms of each research domain. We argue here that technology is now mature to bring community driven benchmarking efforts to a higher level that should allow effective interoperability of benchmarks across related methods. New technological developments allow overcoming the limitations of the first experiences on online benchmarking e.g. EVA. We therefore describe OpenEBench, a novel infra-structure designed to establish a continuous automated benchmarking system for bioinformatics methods, tools and web services. OpenEBench is being developed so as to cater for the needs of the bioinformatics community, especially software developers who need an objective and quantitative way to inform their decisions as well as the larger community of end-users, in their search for unbiased and up-to-date evaluation of bioinformatics methods. As such OpenEBench should soon become a central place for bioinformatics software developers, community-driven benchmarking initiatives, researchers using bioinformatics methods, and funders interested in the result of methods evaluation.
UPCommons. Portal del coneixement obert de la UPC
Publication Contribución de congreso (ConferenceOutput)

Unbiased taxonomic annotation of metagenomic samples

  • Fosso, Bruno
  • Pesole, Graziano
  • Rosselló, Francesc
  • Valiente Feruglio, Gabriel Alejandro|||0000-0001-9194-2703
The classification of reads from a metagenomic sample using a reference taxonomy is usually based on first mapping the reads to the reference sequences and then, classifying each read at a node under the lowest common ancestor of the candidate sequences in the reference taxonomy with the least classification error. However, this taxonomic annotation can be biased by an imbalanced taxonomy and also by the presence of multiple nodes in the taxonomy with the least classification error for a given read. In this paper, we show that the Rand index is a better indicator of classification error than the often used area under the ROC curve and F-measure for both balanced and imbalanced reference taxonomies, and we also address the second source of bias by reducing the taxonomic annotation problem for a whole metagenomic sample to a set cover problem, for which a logarithmic approximation can be obtained in linear time., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Towards a European health research and innovation cloud (HRIC)

  • Aarestrup, Frank M.
  • Gut, Ivo Glynne
  • Sanz, Ferran
  • Van Oyen, Herman
The European Union (EU) initiative on the Digital Transformation of Health and Care (Digicare) aims to provide the conditions necessary for building a secure, flexible, and decentralized digital health infrastructure. Creating a European Health Research and Innovation Cloud (HRIC) within this environment should enable data sharing and analysis for health research across the EU, in compliance with data protection legislation while preserving the full trust of the participants. Such a HRIC should learn from and build on existing data infrastructures, integrate best practices, and focus on the concrete needs of the community in terms of technologies, governance, management, regulation, and ethics requirements. Here, we describe the vision and expected benefits of digital data sharing in health research activities and present a roadmap that fosters the opportunities while answering the challenges of implementing a HRIC. For this, we put forward five specific recommendations and action points to ensure that a European HRIC: i) is built on established standards and guidelines, providing cloud technologies through an open and decentralized infrastructure; ii) is developed and certified to the highest standards of interoperability and data security that can be trusted by all stakeholders; iii) is supported by a robust ethical and legal framework that is compliant with the EU General Data Protection Regulation (GDPR); iv) establishes a proper environment for the training of new generations of data and medical scientists; and v) stimulates research and innovation in transnational collaborations through public and private initiatives and partnerships funded by the EU through Horizon 2020 and Horizon Europe., The workshop participants received funding from the European Union Seventh Program for Research, Technological Development and Demonstration (FP7) and Horizon Research and Innovation Program (H2020) and other European Union programs under the following grant agreements: AETIONOMY (Developing an Aetiology-based Taxonomy of Human Disease—Approaches to Develop a New Taxonomy for Neurological Disorders, IMI-no115568), ANTI-SUPERBUG PCP (ANTISUPERBUG Precommercial Procurement, H2020-no688878), B-CAST (Breast CAncer Stratification understanding the determinants of risk and prognosis of molecular sub-types, H2020-no633784), BRIDGE Health (Bridging information and data generation for evidence-based health policy and research, H2020-no664691), CASyM (Coordinating Action Systems Medicine—Implementation of Systems Medicine across Europe, FP7-n°305033), CENTER-TBI (Collaborative European NeuroTrauma Effectiveness Research in TBI, FP7-no602150), CECM (Centre for New Methods in Computational Diagnostics and Personalized Therapy, H2020-no763734), COLOSSUS (Advancing a Precision Medicine Paradigm in Metastatic Colorectal Cancer: Systems based patient stratification solutions, H2020-no754923), COMPARE (COllaborative Management Platform for detection and Analyses of (Re-)emerging and foodborne outbreaks in Europe, H2020-no643476), CONNECARE (Personalized Connected Care for Complex Chronic Patients, H2020-no689802), CREATIVE (Collaborative REsearch on ACute Traumatic brain Injury in intensiVe care medicine in Europe, FP7-no602714), DEFORM (Define the global and financial impact of research misconduct H2020-no710246), ECCTR (European Cornea and Cell Transplant Registry, FP7-n°709723), E-COMPARED (European COMPARative Effectiveness Research on online Depression, FP7-no603098), ECRIN-IA (European Clinical Research Infrastructures Network- Integrating Activity, FP7-no284395), EHR4CR (Electronic Health Records Systems for Clinical Research, IMI-no115189) eInfraCentral (European E-infrastructures Services Gateway, H2020-no731049), ELIXIR (European Life-science Infrastructure for Biological Information, FP7-n°211601), ELIXIR-EXCELERATE (Fast track ELIXIR implementation and drive early user exploitation across the life sciences, H2020-no676559), eMEN (e-mental health innovation and transnational implementation platform North West Europe, H2020), EMIF (European Medical Information Framework, IMI-no115372), ERA PerMed (ERA-net Cofund in Personalized Medicine, H2020-no779282), eTRIKS (Delivering European Translational Information and Knowledge Management Services, IMI-1-no115446), EuroPOND (Data-driven models for progression of neurological diseases, H2020-n°666992), EurValve (Personalized Decision Support for Heart Valve disease, H2020-no689617), HBP SGA1/SGA2 (Human Brain Project specific grant agreements, H2020-n°720270/785907), ICT4DEPRESSION (User-friendly ICT tools to enhance self-management and effective treatment of depression in the EU, FP7-n°248778), ImpleMentAll (Towards evidence-based tailored implementation strategies for eHealth, H2020-no733025), INSTRUCT-ULTRA (Releasing the full potential of instruct to expand and consolidate infrastructure services for integrated structural life sciences research, H2020-no731005), MASTERMIND (Management of Mental Disorders through Advanced Technologies, CIP-no621000), MeDALL (Mechanisms of the Development of ALLergy, FP7-n°261357), MedBioinformatics (Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities, H2020-n°634143), MIDAS (Meaningful Integration of Data, Analytics and Services, H2020-no727721), MultipleMS (Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalized medicine, H2020-no733161), myPEBS (Randomized Comparison Of Risk-Stratified versus Standard Breast Cancer Screening European Women Aged 40–74, H2020-no755394), OpenAIRE-Advance (Advancing Open Scholarship, H2020-no777541), OpenMedicine (OpenMedicine, H2020-n°643796), PanCareSurFup (PanCare Childhood and Adolescent Cancer Survival Care and Follow-up Studies, FP7-n°257505), PIONEER (Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope, H2020-IMI-2-n°777492), PREPARE (Platform for European Preparedness Against (Re-)emerging Epidemics, FP7-n°602525), Regions4PerMed (Interregional coordination for a deep and fast uptake of personalized health, H2020-no825812), RD-CONNECT (An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research, FP7-no305344), Solve-RD (Solving the unsolved Rare Diseases, H2020-no779257), SPIDIA4P (SPIDIA for Personalized Medicine-Standardization of generic Pre-analytical procedures for In-vitro DIAgnostics for Personalized Medicine, H2020-no733112), SYSCID (A Systems medicine approach to chronic inflammatory disease, H2020-no733100), SysCLAD (Systems prediction of Chronic Allograft Dysfunction, FP7-n°305457), SYSCOL (Systems Biology of Colorectal Cancer, FP7-no258236), SysMedPD (Systems Medicine of Mitochondrial Parkinson’s Disease, H2020-n°668738), U-BIOPRED (Unbiased BIOmarkers for the PREDiction of respiratory disease outcomes, IMI-n°115010), VPH-share (Virtual Physiological Human: Sharing for Healthcare—A Research Environment, FP7-n°269978).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The discovery potential of RNA processing profiles

  • Pagès Pinós, Amadís
  • Dotu, Ivan
  • Pallarès Albanell, Joan, 1988-
  • Martí Puig, Eulàlia
  • Guigó Serra, Roderic
  • Eyras Jiménez, Eduardo
Small non-coding RNAs (sncRNAs) are highly abundant molecules that regulate essential cellular processes and are classified according to sequence and structure. Here we argue that read profiles from size-selected RNA sequencing capture the post-transcriptional processing specific to each RNA family, thereby providing functional information independently of sequence and structure. We developed SeRPeNT, a new computational method that exploits reproducibility across replicates and uses dynamic time-warping and density-based clustering algorithms to identify, characterize and compare sncRNAs by harnessing the power of read profiles. We applied SeRPeNT to: (i) generate an extended human annotation with 671 new sncRNAs from known classes and 131 from new potential classes, (ii) show pervasive differential processing of sncRNAs between cell compartments and (iii) predict new molecules with miRNA-like behaviour from snoRNA, tRNA and long non-coding RNA precursors, potentially dependent on the miRNA biogenesis pathway. Furthermore, we validated experimentally four predicted novel non-coding RNAs: a miRNA, a snoRNA-derived miRNA, a processed tRNA and a new uncharacterized sncRNA. SeRPeNT facilitates fast and accurate discovery and characterization of sncRNAs at an unprecedented scale. SeRPeNT code is available under the MIT license at https://github.com/comprna/SeRPeNT., MINECO (to E.E., A.P.); FEDER [BIO2014-52566-R to E.E., A.P.]; Consolider RNAREG [CSD2009-00080 to E.E., A.P.]; AGAUR [SGR2014-1121 to E.E., A.P.]; European ITN Network RNP-Net [ID:289007 to E.E., A.P.]; Sandra Ibarra Foundation for Cancer [FSI2013 to E.E., A.P.]; MINECO [BIO2011-26205 to R.G., A.P., SAF2014-60551-R to E.M., J.P.A.]; National Human Genome Research Institute of the National Institutes of Health [U54HG007004 to R.G., A.P.]; MINECO Centro de Excelencia Severo Ochoa 2013-2017 [SEV-2012-0208 to R.G., A.P.]; Research Programme on Biomedical Informatics (GRIB), which is member of ELIXIR-Excelerate of the European Union Horizon 2020 Programme 2014-2020 [676559 to E.E., A.P., I.D.]; ELIXIR-Excelerate, European Union Horizon 2020 Spanish National Bioinformatics Institute (INB) [PT13/0001/0023 to E.E., A.P., I.D.]. Funding for open access charge: European ITN Network RNP-Net [ID:289007] and MINECO-FEDER [BIO2014-52566-R].
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Four simple recommendations to encourage best practices in research software

  • Jiménez, Rafael C.
  • Sanz, Ferran
  • Crouch, Steve
Scientific research relies on computer software, yet software is not always developed following practices that ensure its quality and sustainability. This manuscript does not aim to propose new software development best practices, but rather to provide simple recommendations that encourage the adoption of existing best practices. Software development best practices promote better quality software, and better quality software improves the reproducibility and reusability of research. These recommendations are designed around Open Source values, and provide practical suggestions that contribute to making research software and its source code more discoverable, reusable and transparent. This manuscript is aimed at developers, but also at organisations, projects, journals and funders that can increase the quality and sustainability of research software by encouraging the adoption of these recommendations., This work was partially supported by ELIXIR-EXCELERATE and CORBEL. ELIXIR-EXCELERATE and CORBEL are funded by the European Commission within the Research Infrastructures programme of Horizon 2020, grant agreement numbers 676559 and 654248. The European workshops were supported by ELIXIR and organised in collaboration with the Software Sustainability Institute and Netherlands eScience Center. The workshop in Australia was supported by EMBL-ABR via its main funders: The University of Melbourne and Bioplatforms Australia.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Models of cell signaling uncover molecular mechanisms of high-risk neuroblastoma and predict disease outcome

  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Çubut, Cankut
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
Background: Despite the progress in neuroblastoma therapies the mortality of high-risk patients is still high (40–50%) and the molecular basis of the disease remains poorly known. Recently, a mathematical model was used to demonstrate that the network regulating stress signaling by the c-Jun N-terminal kinase pathway played a crucial role in survival of patients with neuroblastoma irrespective of their MYCN amplification status. This demonstrates the enormous potential of computational models of biological modules for the discovery of underlying molecular mechanisms of diseases. Results: Since signaling is known to be highly relevant in cancer, we have used a computational model of the whole cell signaling network to understand the molecular determinants of bad prognostic in neuroblastoma. Our model produced a comprehensive view of the molecular mechanisms of neuroblastoma tumorigenesis and progression. Conclusion: We have also shown how the activity of signaling circuits can be considered a reliable model-based prognostic biomarker. Reviewers: This article was reviewed by Tim Beissbarth, Wenzhong Xiao and Joanna Polanska. For the full reviews, please go to the Reviewers’ comments section.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

PMut: A web-based tool for the annotation of pathological variants on proteins, 2017 update

  • López Ferrando, Víctor
  • Gazzo, Andrea M.
  • Cruz, Xavier de la
  • Orozco, Modesto
  • Gelpí, Josep Lluís
We present here a full update of the PMut predictor, active since 2005 and with a large acceptance in the field of predicting Mendelian pathological mutations. PMut internal engine has been renewed, and converted into a fully featured standalone training and prediction engine that not only powers PMut web portal, but that can generate custom predictors with alternative training sets or validation schemas. PMut Web portal allows the user to perform pathology predictions, to access a complete repository of pre-calculated predictions, and to generate and validate new predictors. The default predictor performs with good quality scores (MCC values of 0.61 on 10-fold cross validation, and 0.42 on a blind test with SwissVar 2016 mutations). The PMut portal is freely accessible at http://mmb.irbbarcelona.org/PMut. A complete help and tutorial is available at http://mmb.irbbarcelona.org/PMut/help., Spanish Ministry of Science [BIO2015-64802-R-32868, SEV-2015-0493, TIN2012-34557, TEC2015-67774-C2-2-R, SAF2016-80255-R]; Catalan Government [2014-SGR-134, 2014-SGR-1051]; Instituto de Salud Carlos III-Instituto Nacional de Bioinformática [INB; PT13/0001/0019, PT13/0001/0028]; European Union, H2020 programme [Elixir-Excelerate: 676559; BioExcel: 674728 and MuG: 676566]; La Caixa Foundation fellowship [to V.L.F.]. Funding for open access charge: European Union and Spanish Ministry of Science.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models

  • Çubut, Cankut
  • Hidalgo, Marta R.
  • Amadoz, Alicia
  • Rian, Kinza
  • Salavert, Francisco
  • Pujana Genestar, M. Ángel
  • Mateo, Francesca
  • Herranz Ors, Carmen, 1992-
  • Carbonell-Caballero, Jose
  • Dopazo, Joaquín
In spite of the increasing availability of genomic and transcriptomic data, there is still a gap between the detection of perturbations in gene expression and the understanding of their contribution to the molecular mechanisms that ultimately account for the phenotype studied. Alterations in the metabolism are behind the initiation and progression of many diseases, including cancer. The wealth of available knowledge on metabolic processes can therefore be used to derive mechanistic models that link gene expression perturbations to changes in metabolic activity that provide relevant clues on molecular mechanisms of disease and drug modes of action (MoA). In particular, pathway modules, which recapitulate the main aspects of metabolism, are especially suitable for this type of modeling. We present Metabolizer, a web-based application that offers an intuitive, easy-to-use interactive interface to analyze differences in pathway metabolic module activities that can also be used for class prediction and in silico prediction of knock-out (KO) effects. Moreover, Metabolizer can automatically predict the optimal KO intervention for restoring a diseased phenotype. We provide different types of validations of some of the predictions made by Metabolizer. Metabolizer is a web tool that allows understanding molecular mechanisms of disease or the MoA of drugs within the context of the metabolism by using gene expression measurements. In addition, this tool automatically suggests potential therapeutic targets for individualized therapeutic interventions., This work is supported by grants SAF2017–88908-R from the Spanish Ministry of Economy and Competitiveness and “Plataforma de Recursos Biomoleculares y Bioinformáticos” PT13/0001/0007 and “Plataforma de Bioinformática” PT17/0009/0006 from the ISCIII, all co-funded with European Regional Development Funds (ERDF); and EU H2020-INFRADEV-1–2015–1 ELIXIR-EXCELERATE (ref. 676559) and EU FP7-People ITN Marie Curie Project (ref 316861). The article was previously published as a preprint: Cankut Cubuk, Marta R Hidalgo, Alicia Amadoz, Kinza Rian, Francisco Salavert, Miguel Angel Pujana, Francesca Mateo, Carmen Herranz, Jose Carbonell Caballero, Joaquin Dopazo. 2018. Differential metabolic activity and discovery of therapeutic targets using summarized metabolic pathway models. bioRxiv https://doi.org/10.1101/367334.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

psygenet2r: a R/Bioconductor package for the analysis of psychiatric disease genes

  • Gutiérrez Sacristán, Alba
  • Hernández Ferrer, Carles
  • González, Juan Ramón
  • Furlong, Laura I.
Motivation: Psychiatric disorders have a great impact on morbidity and mortality. Genotype-phenotype resources for psychiatric diseases are key to enable the translation of research findings to a better care of patients. PsyGeNET is a knowledge resource on psychiatric diseases and their genes, developed by text mining and curated by domain experts. Results: We present psygenet2r, an R package that contains a variety of functions for leveraging PsyGeNET database and facilitating its analysis and interpretation. The package offers different types of queries to the database along with variety of analysis and visualization tools, including the study of the anatomical structures in which the genes are expressed and gaining insight of gene's molecular function. Psygenet2r is especially suited for network medicine analysis of psychiatric disorders. Availability: The package is implemented in R and is available under MIT license from Bioconductor ( http://bioconductor.org/packages/release/bioc/html/psygenet2r.html ). Supplementary information: Supplementary data are available at Bioinformatics online.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Proximal pathway enrichment analysis for targeting comorbid diseases via network endopharmacology

  • Aguirre Plans, Joaquim, 1993-
  • Piñero González, Janet, 1977-
  • Menche, Jörg
  • Sanz, Ferran
  • Furlong, Laura I., 1971-
  • Schmidt, Harald H.H.W.
  • Oliva Miguel, Baldomero
  • Guney, Emre
The past decades have witnessed a paradigm shift from the traditional drug discovery shaped around the idea of "one target, one disease" to polypharmacology (multiple targets, one disease). Given the lack of clear-cut boundaries across disease (endo)phenotypes and genetic heterogeneity across patients, a natural extension to the current polypharmacology paradigm is to target common biological pathways involved in diseases via endopharmacology (multiple targets, multiple diseases). In this study, we present proximal pathway enrichment analysis (PxEA) for pinpointing drugs that target common disease pathways towards network endopharmacology. PxEA uses the topology information of the network of interactions between disease genes, pathway genes, drug targets and other proteins to rank drugs by their interactome-based proximity to pathways shared across multiple diseases, providing unprecedented drug repurposing opportunities. Using PxEA, we show that many drugs indicated for autoimmune disorders are not necessarily specific to the condition of interest, but rather target the common biological pathways across these diseases. Finally, we provide high scoring drug repurposing candidates that can target common mechanisms involved in type 2 diabetes and Alzheimer's disease, two conditions that have recently gained attention due to the increased comorbidity among patients., The authors received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 116030. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. The authors also received support from EU H2020 Programme 2014–2020 under grant agreement No. 676559 (Elixir-Excelerate). E.G. was supported by EU-cofunded Beatriu de Pinós incoming fellowship from the Agency for Management of University and Research Grants (AGAUR) of Government of Catalunya and L.I.F. received support from ISCIII-FEDER (CPII16/00026). H.H.H.W.S. has received funding from from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 777111 (Repotrial). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I+D+i 2013–2016, funded by ISCIII and FEDER. The DCEXS is a “Unidad de Excelencia María de Maeztu”, funded by the MINECO (ref: MDM-2014-0370)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Open PHACTS computational protocols for in silico target validation of cellular phenotypic screens: knowing the knowns.

  • Digles, Daniela
  • Queralt Rosinach, Núria
  • Furlong, Laura I., 1971-
  • Jacoby, Edgar
Phenotypic screening is in a renaissance phase and is expected by many academic and industry leaders to accelerate the discovery of new drugs for new biology. Given that phenotypic screening is per definition target agnostic, the emphasis of in silico and in vitro follow-up work is on the exploration of possible molecular mechanisms and efficacy targets underlying the biological processes interrogated by the phenotypic screening experiments. Herein, we present six exemplar computational protocols for the interpretation of cellular phenotypic screens based on the integration of compound, target, pathway, and disease data established by the IMI Open PHACTS project. The protocols annotate phenotypic hit lists and allow follow-up experiments and mechanistic conclusions. The annotations included are from ChEMBL, ChEBI, GO, WikiPathways and DisGeNET. Also provided are protocols which select from the IUPHAR/BPS Guide to PHARMACOLOGY interaction file selective compounds to probe potential targets and a correlation robot which systematically aims to identify an overlap of active compounds in both the phenotypic as well as any kinase assay. The protocols are applied to a phenotypic pre-lamin A/C splicing assay selected from the ChEMBL database to illustrate the process. The computational protocols make use of the Open PHACTS API and data and are built within the Pipeline Pilot and KNIME workflow tools., The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115191, resources of which are composed of financial contributions from the EU's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in-kind contribution. L. I. F. received support from ISCIII-FEDER (PI13/00082, CP10/00524) and the EU H2020 Programme 2014-2020 under grant agreements no. 634143 (MedBioinformatics) and no. 676559 (Elixir-Excelerate). The Research Programme on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The Multiple Roles of Waters in Protein Solvation

  • Hospital, Adam
  • Candotti, Michela
  • Gelpí, Josep Lluís
  • Orozco, Modesto
Extensive molecular dynamics (MD) simulations have been used to characterize the multiple roles of water in solvating different types of proteins under different environmental conditions. We analyzed a small set of proteins, representative of the most prevalent meta-folds under native conditions, in the presence of crowding agents, and at high temperature with or without high concentration of urea. We considered also a protein in the unfolded state as characterized by NMR and atomistic MD simulations. Our results outline the main characteristics of the hydration environment of proteins and illustrate the dramatic plasticity of water, and its chameleonic ability to stabilize proteins under a variety of conditions., The authors thank INB (Instituto Nacional de Bioinformática) for support in this project. Additional funding to this project comes from H2020 (BioExcel GA 675728, Elixir-Excelerate GA 676559) and the Spanish MINECO (BIO2015/64802-R) funding agencies. IRB Barcelona is recipient of a Severo Ochoa Award of Excellence from MINECO (Government of Spain, GA SEV-2015-050). MO is an ICREA Academia researcher., Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

From Wet-Lab to Variations: Concordance and Speed of Bioinformatics Pipelines for Whole Genome and Whole Exome Sequencing

  • Laurie, Steven, 1973-
  • Fernández Callejo, Marcos
  • Marco Sola, Santiago
  • Trotta, Jean-Remi
  • Camps-Puchadas, Jordi
  • Chacón, Alejandro
  • Espinosa, Antonio
  • Gut, Marta
  • Gut, Ivo Glynne
  • Heath, Simon
  • Beltran, Sergi
As whole genome sequencing becomes cheaper and faster, it will progressively substitute targeted next-generation sequencing as standard practice in research and diagnostics. However, computing cost–performance ratio is not advancing at an equivalent rate. Therefore, it is essential to evaluate the robustness of the variant detection process taking into account the computing resources required. We have benchmarked six combinations of state-of-the-art read aligners (BWA-MEM and GEM3) and variant callers (FreeBayes, GATK HaplotypeCaller, SAMtools) on whole genome and whole exome sequencing data from the NA12878 human sample. Results have been compared between them and against the NIST Genome in a Bottle (GIAB) variants reference dataset. We report differences in speed of up to 20 times in some steps of the process and have observed that SNV, and to a lesser extent InDel, detection is highly consistent in 70% of the genome. SNV, and especially InDel, detection is less reliable in 20% of the genome, and almost unfeasible in the remaining 10%. These findings will aid in choosing the appropriate tools bearing in mind objectives, workload, and computing infrastructure available., Contract Grant Sponsors: Spanish Ministry of Economy and Competitiveness; Generalitat de Catalunya; European Regional Development Fund (ERDF); RD-Connect Project (EC FP7/2007-2013 #305444); ELIXIR-EXCELERATE (EC H2020 #676559); MICINN (TIN2014-53234- C2-1-R).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The multiple roles of waters in protein solvation

  • Hospital Gasch, Adam
  • Candotti, Michela
  • Gelpí Buchaca, Josep Lluís
  • Orozco López, Modesto
Extensive molecular dynamics (MD) simulations have been used to characterize the multiple roles of water in solvating different types of proteins under different environmental conditions. We analyzed a small set of proteins, representative of the most prevalent meta-folds under native conditions, in the presence of crowding agents, and at high temperature with or without high concentration of urea. We considered also a protein in the unfolded state as characterized by NMR and atomistic MD simulations. Our results outline the main characteristics of the hydration environment of proteins and illustrate the dramatic plasticity of water, and its chameleonic ability to stabilize proteins under a variety of conditions.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Patient dossier: healthcare queries over distributed resources

  • Vazquez, Miguel
  • Valencia, Alfonso
As with many other aspects of the modern world, in healthcare, the explosion of data and resources opens new opportunities for the development of added-value services. Still, a number of specific conditions on this domain greatly hinders these developments, including ethical and legal issues, fragmentation of the relevant data in different locations, and a level of (meta)data complexity that requires great expertise across technical, clinical, and biological domains. We propose the Patient Dossier paradigm as a way to organize new innovative healthcare services that sorts the current limitations. The Patient Dossier conceptual framework identifies the different issues and suggests how they can be tackled in a safe, efficient, and responsible way while opening options for independent development for different players in the healthcare sector. An initial implementation of the Patient Dossier concepts in the Rbbt framework is available as open-source at https://github.com/mikisvaz and https://github.com/Rbbt-Workflows., This work has received funding from the Elixir-Excelerate project, from the European Union's Horizon 2020 Research and Innovation Programme, under grant agreement N. 676559, and from Plataforma de Recursos Biomoleculares y Bioinformáticos PT13/0001/0030. Additional support came from the Lenovo - BSC Master Collaboration Agreement (2015) and from the IBM-BSC Deep Learning Centre (2016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

ResMarkerDB: a database of biomarkers of response to antibody therapy in breast and colorectal cancer

  • Pérez-Granado, Judith
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
The clinical efficacy of therapeutic monoclonal antibodies for breast and colorectal cancer has greatly contributed to the improvement of patients' outcomes by individualizing their treatments according to their genomic background. However, primary or acquired resistance to treatment reduces its efficacy. In this context, the identification of biomarkers predictive of drug response would support research and development of new alternative treatments. Biomarkers play a major role in the genomic revolution, supporting disease diagnosis and treatment decision-making. Currently, several molecular biomarkers of treatment response for breast and colorectal cancer have been described. However, information on these biomarkers is scattered across several resources, and needs to be identified, collected and properly integrated to be fully exploited to inform monitoring of drug response in patients. Therefore, there is a need of resources that offer biomarker data in a harmonized manner to the user to support the identification of actionable biomarkers of response to treatment in cancer. ResMarkerDB was developed as a comprehensive resource of biomarkers of drug response in colorectal and breast cancer. It integrates data of biomarkers of drug response from existing repositories, and new data extracted and curated from the literature (referred as ResCur). ResMarkerDB currently features 266 biomarkers of diverse nature. Twenty-five percent of these biomarkers are exclusive of ResMarkerDB. Furthermore, ResMarkerDB is one of the few resources offering non-coding DNA data in response to drug treatment. The database contains more than 500 biomarker-drug-tumour associations, covering more than 100 genes. ResMarkerDB provides a web interface to facilitate the exploration of the current knowledge of biomarkers of response in breast and colorectal cancer. It aims to enhance translational research efforts in identifying actionable biomarkers of drug response in cancer., Instituto de Salud Carlos III-Fondo Europeo de Desarrollo Regional [grant numbers: PIE15/00008, CP10/00524, CPII16/00026]; Instituto de Salud Carlos III-Fondo Social Europeo [FI18/00034]; and the European Commission Horizon 2020 Programme 2014–2020 under grant agreements MedBioinformatics [grant number: 634143] and Elixir-Excelerate [grant number: 676559]. The Research Programme on Biomedical Informatics is a member of the Spanish National Bioinformatics Institute, Plataforma de Recursos Biomoleculares y Bioinformáticos-Instituto de Salud Carlos III [grant number: PT13/0001/0023], of the PE I + D + i 2013–2016, funded by Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional. The Departamento de Ciencias Experimentales y de la Salud is a Unidad de Excelencia María de Maeztu, funded by the Ministerio de Economía y Competitividad (reference number: MDM-2014-0370).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The Functional Impact of Alternative Splicing in Cancer

  • Climente-Gonzalez, Héctor
  • Porta-Pardo, Eduard
  • Godzik, Adam
  • Eyras, Eduardo
Alternative splicing changes are frequently observed in cancer and are starting to be recognized as important signatures for tumor progression and therapy. However, their functional impact and relevance to tumorigenesis remain mostly unknown. We carried out a systematic analysis to characterize the potential functional consequences of alternative splicing changes in thousands of tumor samples. This analysis revealed that a subset of alternative splicing changes affect protein domain families that are frequently mutated in tumors and potentially disrupt protein-protein interactions in cancer-related pathways. Moreover, there was a negative correlation between the number of these alternative splicing changes in a sample and the number of somatic mutations in drivers. We propose that a subset of the alternative splicing changes observed in tumors may represent independent oncogenic processes that could be relevant to explain the functional transformations in cancer, and some of them could potentially be considered alternative splicing drivers (AS drivers)., H.C.-G. and E.E. were supported by the MINECO and FEDER (BIO2014-52566-R), Consolider RNAREG (CSD2009-00080), AGAUR (SGR2014-1121), the European ITN Network RNP-Net (ID: 289007), and the Sandra Ibarra Foundation for Cancer (FSI2013). E.P.-P. and A.G. were supported by the SBP CC grant (P30 CA030199). All authors thank The Cancer Genome Atlas project for making their data publicly available. The Computational RNA Biology Group is part of the Research Programme on Biomedical Informatics (GRIB), which is a member of ELIXIR-Excelerate of the European Union Horizon 2020 Programme 2014-2020 (No. 676559) and of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023 of the PE I+D+I 2013-2016, funded by ISCIII and FEDER., Peer Reviewed, Postprint (published version)